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ABSTRACT OF DISSERTATION

EFFECT OF CHRONIC AIRWAY INFLAMMTION INDUCED BY ALLERGEN
SENSITIZATION ON VAGAL BRONCHOPULMOANRY SENSORY NERVES
IN RATS
Airway hyperresponsivness (AHR) is one of most prominent pathophysiological
features of asthma. Increasing evidence suggests that vagal bronchopulmonary afferents
may be involved in the development of AHR. However, the underlying mechanisms are
not clear. Therefore, the purpose of this dissertation was to investigate the effect of
chronic airway inflammation induced by allergen sensitization on vagal
bronchopulmonary afferents. The study was carried out in an animal model of allergic
asthma. Brown-Norway rats were sensitized by intraperitoneal Ovalbumin (Ova) and
exposed to aerosolized Ova 3 times/week for three weeks. Control rats received the
vehicle. In vivo single-fiber recording technique was applied in this study. Our results
showed that chronic Ova exposure caused an elevated baseline activity of pulmonary Cfibers, and a distinctly higher sensitivity of these afferents to chemical stimulants and
lung inflation. After an acute Ova inhalation challenge, the increase in baseline activity
and the excitability of pulmonary C-fibers were further augmented in sensitized rats, but
not in control rats. In addition, sensitivity of pulmonary myelinated afferents to capsaicin
was significantly elevated after chronic airway inflammation was induced by allergen.
Furthermore, immunohistochemsitry data showed that, in nodose ganglia the proportion
of transient receptor potential vanilloids type 1 channels (TRPV1)-expressing
bronchopulmonary neurons was significantly higher in sensitized rats than in controls.
This increase of TRPV1 expression was found mainly in neurofilament-positive neurons
(myelinated neurons), but this effect was absent in jugular ganglia. In conclusion,
allergen-induced airway inflammation caused a pronounced sensitizing effect on vagal
pulmonary non-myelinated (C-fiber) afferents and elevated the sensitivity of vagal
pulmonary myelinated afferents to capsaicin. The latter was accompanied by the
upregulation of TRPV1 expression in these myelinated neurons.
Keywords: asthma; allergen; vagus; TRPV1; capsaicin.

Guangfan Zhang
------------------------------------01/07/2009
-------------------------------------

EFFECT OF CHRONIC AIRWAY INFLAMMATION INDUCED BY ALLERGEN
SENSITIZATION ON VAGAL BRONCHOPULMONARY SENSORY NERVES
IN RATS

By
Guangfan Zhang

Lu-Yuan Lee
--------------------------------------Director of Dissertation
OK-Kyong Park-Sarge
--------------------------------------Director of Graduate Studies
01/07/2009
--------------------------------------Date

RULES FOR THE USE OF DISSERTATIONS

Unpublished dissertation submitted for the Doctor’s degree and deposited in University
of Kentucky Library are as a rule open for inspection, but are to be used only with due
regard to the rights of the authors. Bibliographical references may be noted, but
quotations or summaries of parts may be published only with the permission of the author,
and with the usual scholarly acknowledgements.
Extensive copying or publication of the dissertation in whole or in part also requires the
consent of the Dean of the Graduate School of the University of Kentucky.
A library that borrows this dissertation for use by its patron is expected to secure the
signature of each user.

Name

Date

DISSERTATION

Guangfan Zhang

The Graduate School
University of Kentucky
2009

EFFECT OF CHRONIC AIRWAY INFLAMMATION INDUCED BY ALLERGEN
SENSITIZATION ON VAGAL BRONCHOPULMONARY SENSORY NERVES
IN RATS

------------------------------------------DISSERTATION
------------------------------------------A dissertation submitted in partial fulfillment of the
requirements of the degree of Doctor of Physiology in the
College of Medicine at the University of Kentucky

By
Guangfan Zhang
Lexington, Kentucky
Director: Dr. Lu-Yuan Lee, Professor of Physiology
Lexington, Kentucky
2009
Copyright © Guangfan Zhang 2009

For my loving parents, Naiyang Zhang and Huanqin Zhang

ACKNOWLEGEMENTS

This dissertation would not have been written without the contribution from many
people. I owe my gratitude to all those people who have made this dissertation possible
and because of whom my graduate experience has been one that I will cherish forever.
My deepest gratitude is to my mentor, Dr. Lu-Yuan Lee. I have been amazingly
fortunate to have an advisor who gave me the guidance to recover when my steps faltered
and also gave me the freedom to explore by my own. His patience and support helped me
to overcome many crisis situations and finish this dissertation. I am also indebted to the
members of our laboratory, Dr. David Gu for carefully reading and commenting on
countless revisions of my manuscripts and Libby Lim, Ruei-lung Lin and Bob Morton for
their assistance.
I would like to thank the members of my committee, Dr. Timothy McClintock, Dr.
Steven Estus and Dr. Diane Snow. Their insightful comments and constructive criticisms
at different stages of my research were thought-provoking and they helped me to
complete my dissertation. In particular, I am deeply grateful to Dr. Snow for her guidance
and advice in the design of my immunohistochemistry experiments and for allowing me
to use the facilities in her lab. She has been always there to listen and help me to sort out
the technical details of my work and enforce strict validations for each research result.
Additionally, I would like to thank Dr. Don Cohen for his willingness to serve as my
outside examiner.

iii

I am grateful to Dr. Neeraja Sammeta and other members in Dr. McClontock’s
lab for their encouragement and practical advices for my experiments. I am also thankful
to Chris Calulot in Dr. Snow’ lab and Cynthia Long for helping me in
immunohistochemistry experiments.
The last and certain not least, I would like to thank my family: my mom and dad:
Huanqin and Naiyang; my brother: Lei. Their unending support and love accompany me
through all the tough times. Most importantly, I would like to thank the love of my life,
my husband Zhan, who has been so incredible supportive of all my pursuits. Finally, I
would like to thank my sweet heart, my daughter Sarah, who is my forever motivation.

iv

TABLE OF CONTENTS

Acknowledgements............................................................................................................ iii
List of Tables ..................................................................................................................... vi
List of Figures ................................................................................................................... vii
Chapter One: Introduction
1.1 Background .....................................................................................................1
1.2 Rationale and Hypothesis .............................................................................13
Chapter Two: Sensitizing Effects of Chronic Exposure and Acute Inhalation of Ovalbumin
Aerosol on Pulmonary C-fibers in Rats
2.1 Specific Aim .................................................................................................15
2.2 Methods.........................................................................................................15
2.3 Results...........................................................................................................22
Chapter Three: Altered Expression of TRPV1 and Sensitivity to Capsaicin in Pulmonary
Myelinated Afferents following Chronic Airway Inflammation in the Rat
3.1 Specific Aim .................................................................................................41
3.2 Methods.........................................................................................................41
3.3 Results...........................................................................................................49
Chapter Four: Discussion and Conclusions .......................................................................71
Appendices (A list of abbreviations) .................................................................................88
References..........................................................................................................................91
Vita...................................................................................................................................102

v

LIST OF TABLES

Table 2.1

Effect of Ova sensitization on leukocyte counts in BALF collected at 4-6
hours after the acute Ova inhalation challenge.......................................27

Table 2.2

Effects of acute Ova inhalation challenge on average baseline MABP
and HR in both control and sensitized rats .............................................28

Table 3.1

Expression of TRPV1-immunoreactivity in myelinated and nonmyelinated pulmonary neurons in nodose and jugular ganglia ..............55

vi

LIST OF FIGURES

Figure 1.1

Neurogenic inflammations in asthmatic airways via retrograde release of
peptides from sensory nerves via an axon reflex......................................8

Figure 1.2

TRPV1 is an integrator of inflammatory pain pathways ........................12

Figure 2.1

Experimental Setup for exposure of rats to Ova aerosol ........................29

Figure 2.2

Responses of RL (total pulmonary resistance) and Cdyn (dynamic lung
compliance) to acute inhalation of Ova aerosol (3%, 5 min) .................30

Figure 2.3

Dose responses of RL (total pulmonary resistance) and Cdyn (dynamic
lung compliance) to aerosolized methacholine (MCh) in control and
sensitized rats..........................................................................................31

Figure 2.4

The average baseline fiber activities before and after acute Ova
challenge in anesthetized, open-chest and artificially ventilated rats.....32

Figure 2.5

Experimental records illustrating the effects of acute Ova challenge on
the pulmonary C-fiber responses to lung inflation in anesthetized, openchest and artificially ventilated rats ........................................................33

Figure 2.6

Effect of Ova sensitization on the average responses of pulmonary Cfibers to lung inflation in anesthetized, open-chest and artificially
ventilated rats..........................................................................................34

Figure 2.7

Experimental records illustrating the effects of acute Ova inhalation
challenge on the pulmonary C-fiber responses to capsaicin in
anesthetized, open-chest and artificially ventilated rats .........................35

vii

Figure 2.8

Effects of acute Ova inhalation challenge on pulmonary C-fiber activity
and cardiovascular responses to capsaicin in anesthetized and open-chest
rats...........................................................................................................36

Figure 2.9

Effect of Ova sensitization on the average peak response and the
duration of discharge of pulmonary C-fibers in response to right-atrial
bolus injection of capsaicin in anesthetized, open-chest and artificially
ventilated rats..........................................................................................37

Figure 2.10

Effect of Ova sensitization on the average peak response and the
duration of discharge of pulmonary C-fibers in response to right-atrial
bolus injection of adenosine in anesthetized, open-chest and artificially
ventilated rats..........................................................................................39

Figure 3.1

TRPV1 antibody specificity test (panels A and B) and IHC controls for
TRPV1 and NF (panel C) .......................................................................56

Figure 3.2

Experimental records illustrating the effect of perineural capsaicin
treatment (PNCT) of both cervical vagi on cardiorespiratory responses
to capsaicin injection ..............................................................................58

Figure 3.3

Experimental records illustrating the responses of silent RARs to lung
inflation, deflation and capsaicin injection in anesthetized, vagotomized,
open-chest and artificially ventilated rats ...............................................60

Figure 3.4

Average baseline fiber activities (FA) and the responses of silent (si)
RARs, phasic (ph) RARs and SARs to lung inflation in anesthetized,
vagotomized, open-chest and artificially ventilated rats ........................61

viii

Figure 3.5

Experimental records illustrating the responses of SARs to lung inflation,
deflation and capsaicin injection in anesthetized, vagotomized, openchest and artificially ventilated rats ........................................................62

Figure 3.6

Effect of Ova sensitization on responses of myelinated afferents to rightatrial injection of capsaicin in anesthetized, vagotomized, open-chest
and artificially ventilated rats .................................................................63

Figure 3.7

Effect of Ova sensitization on TRPV1 expression in pulmonary neurons
in nodose and jugular ganglia .................................................................65

Figure 3.8

Effect of Ova sensitization on TRPV1 expression in NF-positive and
NF-negative neurons with DiI labeling in nodose ganglion ...................67

Figure 3.9

Effect of Ova sensitization on TRPV1 expression in NF-positive and
NF-negative neurons with DiI labeling in jugular ganglion ...................69

ix

CHAPTER ONE
Introduction

1.1 Background
Asthma
Asthma is a life-threatening lung disease that causes various problems in
breathing (e.g., airway obstruction, hypoxia, shortness of breath, coughing etc.). In the
United States, asthma prevalence has been increasing since the early 1980s in all ages
and racial groups, and in both sexes. It affects an estimated 14.9 million persons and
cause over 1.5 million emergency hospital visits, about 500,000 hospitalizations, and
over 5,500 deaths in 1995. The estimated direct and indirect monetary costs for this
disease added up to $11.3 billion in 1998 [1]. Therefore, in addition to the high
prevalence of asthma, asthma remains a major illness in terms of mobility, suffering and
financially cost. It is very important to understand the pathogenetic mechanisms of
asthma.
Asthma is a disease characterized by episodic and reversible airway obstruction
and inflammation, accompanied by airway hyperresponsiveness (AHR), which is defined
as an increased bronchoconstrictive response to bronchial provocative challenge [2]. The
exact cause of asthma remains uncertain, but, it is known that several factors may
contribute to the development of this disease, for example, genetic factors (e.g., a history
of asthma in the family), environmental factors (e.g., air pollution, occupational exposure,
viral infections and allergen exposure) and life style factors (e.g., smoking). In
susceptible individuals, asthma causes recurrent episodes of wheezing, breathlessness,
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chest tightness and coughing [3]. The development of allergic asthma episodes consists
of three phases, namely the induction phase, the early-phase asthmatic response (EAR),
and the late-phase asthmatic response (LAR). Each phase is characterized by the
production and interaction of various cell-derived mediators. In the induction phase, T
helper (TH) cytokines are important in the development of asthma. Inhaled allergens that
escape the mucociliary clearance are taken up and processed by antigen presenting cells
(APCs), which are distributed throughout the respiratory tract, from the nasal mucosa to
the lung pleura. These APCs then migrate to the lymph nodes where the processed
allergen is presented to allergen specific T and B cells [4, 5]. Interactions between those
cells elicit responses that are influenced by secreted cytokines and cell-bound costimulatory molecules. Activation of TH cells by APCs leads to the production of
cytokines that regulate the isotype switch of B cells in their production of
immunoglobulin (Ig) E [4]. Once synthesized, IgE antibodies circulate in the blood
before binding to the high-affinity IgE receptor FcεRI that is present on mast cells in
tissues or on peripheral blood basophils. After re-exposure, allergens cross-link to mast
cell bound specific IgE, causing the activation of cellular signaling pathways, which
subsequently trigger the release of preformed mediators, such as histamine, the synthesis
of prostaglandins (PGs) and leukotrienes (LTs), and the transcription of cytokines by
mast cells [6]. These mediators cause the so-called EAR,
The EAR is characterized by constriction of airway smooth muscle cells, vascular
leakage, mucus production, enhanced AHR and recruitment of inflammatory cells [7].
The EAR occurs almost immediately, lasting for 30–60 min and 4–12 h later followed by
LAR [8].
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The LAR is characterized by excessive inflammation of the airways. The
inflammatory molecules are produced by various cell types, such as eosinophils,
neutrophils, T cells, macrophages, dendritic cells, and structural cells. Chronic
inflammation leads to structural changes in the airways, including airway wall thickening,
subepithelial fibrosis, goblet cell hyperplasia, myofibroblast hyperplasia, airway smooth
muscle cell hyperplasia and hypertrophy, and epithelial hypertrophy [9]. These are
collectively known as airway remodeling.

An animal model of allergic asthma
Animal models of asthma have been developed in various animal species. Rat has
been shown to have several advantages as a model for asthma compared to other species
[10, 11]. For example, the layers of the submucosal and bronchial muscle are thicker in
rats compare to mice. The blood supply of bronchial mucosa in rat comes from the
bronchial artery, which is similar to human. The lamina propria of bronchi in rats
contains capillaries and veins in contrast to mice, which is a very important feature for
the development of airway inflammation since these vessels are the exit site of leukocytes
leading to mucosal inflammation and epithelial damage in asthma in humans and other
species. Adhesion molecules are expressed in lamina propria after allergen exposure in
human biopsy specimens. A swelling of the bronchi mucosa, possibly due to dilation of
bronchial blood vessels, followed by congestion and edema, has often been described in
fetal asthma. Thus, these anatomical features of the proprietary bronchial mucosa in rats
are very similar to those in humans. The rat asthma model also has other similarities with
human asthma such as the production of IgE in response to allergens, the accumulation of
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lymphocytes and eosinophils in the lung lavage and tissue, and the characteristic
elevation of TH2 cytokines. Taken together, rat is considered a good model to study
human asthma [10].
Brown-Norway (BN) rats represent a TH2-like immunophenotype and have been
established as a “classic” animal model of allergic asthma [12-14], because many of the
pathological features of human asthma are seen in this model after antigen challenges,
including the presence of eosinophilic lung inflammation during LAR, damage to the
airway epithelium, thickening of basement membrane, early and late phase airway
responses, and the presence of AHR. It is also known that BN rats have more pronounced
IgE production and inflammatory responses to challenge following sensitization
compared with other strains [15]. These features of sensitized BN rats provide a good
model in which to investigate the mechanisms of human asthma.

Bronchopulmonary sensory afferents
Vagus nerve supplies most of the sensory nerve fibers to the airways and lung. Cell
bodies of these afferent fibers reside in the nodose and jugular ganglia, projecting
centrally to the nucleus tractus solitarius, thus relaying the information from the lung and
airways to the medullar respiratory center.
There are three major types of sensory receptors in vagus bronchopulmonary
afferents.
1) Slowly adapting pulmonary receptors (SARs): myelinated afferents in vagus
nerve that have a fast conduction velocity. The discharge pattern of SARs is
synchronized with respiratory cycles. Their activities are closely related to the degree
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of lung inflation, with a low volume threshold; they are inhibited by deflation and
adapt slowly to maintained lung inflation. Activation of SARs causes the relaxation
of airway smooth muscle, shortens inspiration and prolongs expiration. Thus, these
nerves are responsible for the Hering-Breuer inflation reflex, which inhibits sustained
inspiratory activity. They also lead to a reflex bronchodilation by inhibiting vagal
tone. The evidence that SARs can be activated by reflex-induced or drug (such as
histamine and acetylcholine)-induced smooth muscle contraction suggests that the
location of these receptors is in the vicinity of airway smooth muscle. Although SARs
are generally considered as a mechano-sensitive receptor and less sensitive to
chemical stimulants, their activity can be inhibited by CO2, and may be stimulated by
volatile anesthetics such as halothanes [16].

2) Rapidly adapting pulmonary receptors (RARs): receptors whose activities are
generated in myelinated nerves. The sensory terminals of RARs are believed to lie
under the airway epithelium. RARs respond with a rapidly adapting discharge to a
maintained lung inflation. The majority of RARs are consistently stimulated by
deflation of the lung (below the resting lung volume), and thus they were also named
“deflation receptor”. RARs have a wide range of physiological properties. Those in
the nasopharynx, and many in the trachea discharge only during the application and
removal of a mechanical stimulus. They are usually silent in eupnea and are
extremely sensitive to mechanical stimuli, but are not very sensitive to the direct
application of chemical agents. RARs in the larynx and the trachea are very sensitive
to particulate irritants (cigarette smoke, dust), and, therefore, have been termed the
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“cough receptor”. Intrapulmonary RARs can be stimulated by gases such as ammonia,
sulfur dioxide and ozone and also by histamine, or serotonin. Generally, stimulation
of RARs causes cough, augmented breath and the expiration reflex [17-19].

3) Vagal bronchopulmonary C-fibers: they represent more than 75% of sensory
nerves innervating the entire respiratory tract including larynx, trachea, bronchial,
bronchioles and lung [20]. The sensory terminals of these non-myelinated afferents
are usually located either underneath or between airway epithelial cells [21, 22].
These afferents are relatively insensitive to mechanical stimuli, but are extremely
sensitive to chemical stimuli including inhaled irritants such as acid aerosol, capsaicin,
and endogenous mediators, such as bradykinin and prostaglandins, released during
tissue inflammatory and allergic reactions [23, 24].
The afferent activity arising from these C-fiber endings plays an important role in
regulating respiratory and cardiovascular function under both normal and abnormal
physiologic conditions [23]. The primary function of these neurons under normal
physiological conditions is protective: when the sensory terminals are activated by
irritants or circulated autacoids, action potentials are conducted through the vagus
nerves to the commissural subnucleus of the nucleus tractus solitarius and elicit the
pulmonary chemoreflex that includes apnea, bronchoconstriction, mucus secretion,
cough, bradycardia and hypotension. These responses limit further infiltration of the
irritants deeper into the lung. Under certain pathological states, however, these
afferent nerves develop hypersensitivity, and exaggerated reflex responses become
deleterious to normal airway function [23, 25]. Activation of C-fiber sensory nerves
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may release neuropeptides such as substance P (SP), neurokinin A (NKA) and
calcitonin gene-related peptide (CGRP), which are known to act on a number of
effector cells in the respiratory tract (e.g., airway and vascular smooth muscles,
cholinergic

ganglia,

inflammatory

cells

and

mucous

glands),

and

cause

bronchoconstriction, protein extravasation, airway mucosal edema and inflammatory
cell chemotaxis. These reactions are known as “neurogenic inflammation”[26] . There
is a close relationship between asthma and neurogenic inflammation (Fig. 1.1). In
asthma, damage to airway epithelium, possibly caused by eosinophil products,
exposes C-fiber afferent nerve endings. Stimulation of these endings by inflammatory
mediators such as bradykinin may result in an axon (local) reflex and release of
sensory neuropeptides [27]. Studies on human airways suggest an increased synthesis
of SP in the airways of asthmatic patients [28]. The augmented bronchoconstrictive
effect caused by allergen challenge can be attenuated by the deletion of the
neuropeptide stored in these sensory nerves in guinea pigs [29, 30].
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Fig. 1.1. Neurogenic inflammation in asthmatic airways due to retrograde release of
peptides from sensory nerves via axon reflex. (Modified from Barnes, 2001)
SP causes vasodilatation, plasma exudation and mucus secretion. NKA causes
bronchoconstriction, enhanced cholinergic reflexes, and CGRP vasodilatation.

Afferent nerve fibers can also be classified anatomically by the location of their
cell bodies. The nodose and jugular ganglia have distinct embryological origins. The
nodose ganglion is derived from placodes, while the jugular ganglion is derived from
cells of the neural crest [31]. It is therefore not surprising that there are different
phenotypes of afferents arising from these two ganglia. In the guinea pig airways, the
jugular ganglia contain the cell bodies of myelinated Aδ and unmyelinated C-fibers. The
C-fibers rising from jugular ganglion neurons innervate both the extrapulmonary airways
(larynx, trachea and bronchus) and the lung parenchymal tissue. The myelinated fibers
from jugular ganglion have a lower threshold to mechanical stimuli and respond
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vigorously to classic nociceptive fiber-selective stimuli such as capsaicin and bradykinin.
In comparison, myelinated afferents from nodose ganglia are exquisitely sensitive to
punctate mechanical stimuli but respond poorly to stretch, and do not respond to a variety
of chemical stimuli including capsaicin and bradykinin. In addition, neural crest-derived
C-fibers innervating the pulmonary system are more likely to express neuropeptides such
as SP and CGRP than those derived from placodes [31, 32].

Transient receptor potential vanilloid type 1 ion channel
One prominent feature of pulmonary C-fibers is the expression of transient receptor
potential vanilloid type 1 (TRPV1) channels, a member of transient receptor potential
vanilloid (TRPV) channel family, at the sensory terminal [33]. TRPV1 was first cloned
from rodent dorsal root ganglion (DRG) neurons [34] and is a ligand-gated, nonspecific
cation channel with six transmembrane domains (Fig. 1.2) [35]. TRPV1, a 426 (in the rat)
amino acid protein [34], is uniquely sensitive to vanilloid molecules including capsaicin,
the pungent component in the hot pepper, and is also activated by low extracellular pH
(pH 6–5) [36, 37], elevated concentrations (in the micromolar range) of the
endocannabionoid, anandamide [38], the lipoxygenase metabolites of arachidonic acid,
leukotriene B4 (LTB4) or 12-hydroperoxyeicosatetraenoic acids (12-HPETE) [39] and Narachidonoyl-dopamine [40]. In addition, TRPV1 is a thermosensor, activated by
moderate noxious temperature between 42 and 53°C [34]. A recent study in our labs has
further demonstrated that the TRPV1 expressed in pulmonary-sensory neurons has a
lower temperature threshold for activation (~39°C) [41].
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The expression of TRPV1 is very broad in both neuronal and non-neuronal tissues
such as DRG, the keratinocytes of epidermis, and bladder [42-44]. The presence of
TRPV1 has also been confirmed in human airways, mainly in non-myelinated sensory
nerves from the vagal ganglia [45-47]. Activation of TRPV1 channels on airway sensory
nerves induces Ca2+ influx into the neuronal cell, membrane depolarization and action
potentials. Therefore, activation of these non-myelinated vagal sensory terminals in the
airways can elicit extensive reflex responses mediated through cholinergic pathway and
axon reflex [48], and trigger the release of neuropeptides from both peripheral and central
nerve terminals [49].
The expression of mRNA and protein as well as function of the TRPV1 channel in
neurons can undergo marked plasticity upon the action of a series of regulatory and
inflammatory mediators (Fig. 1.2) [50]. For instance, nerve growth factor (NGF)
increases TRPV1 protein transportation to the peripheral endings of sensory neurons, a
phenomenon associated with an increase in heat hypersensitivity via a p38 mitogenactivated protein (MAP) kinase [51]. Protein kinases (PK) A and C, and phospholipase A
and C metabolites can also modulate TRPV1 function. The threshold temperature for
TRPV1 stimulation is lowered by anandamide through a PKC dependent pathway [52].
The major proinflammatory peptide, bradykinin via activation of the B2 receptor,
sensitizes TRPV1 by different intracellular mechanisms, including PKC-ε [52, 53],
displacement of phosphinositide-4,5-bisphosphate (PIP2) from TRPV1 binding [54], and
12- and 5-lipoxygenase metabolites production [55, 56]. A recent study shows that PGE2
can sensitize TRPV1 channels through EP1 prostanoid receptors, predominantly through
a PKC-dependent pathway in mouse DRG neurons. The temperature threshold for
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TRPV1 channel activation was reduced to below 35°C after PGE2 treatment [57]. Our lab
has shown that PGE2 activates the Gs protein-coupled EP2 prostanoid receptor present on
the membrane of vagal sensory neurons. Then, the stimulation of PKA by the increase in
cyclic AMP (cAMP) increases the phosphorylation of TRPV1 and enhances its
excitability [58].
Extensive evidence has suggested a potential involvement of TRPV1 channels in the
pathogenesis of asthma. Endogenous TRPV1 activators, such as hydrogen ion and
lipoxygenase products, have been detected in asthmatic patients [59, 60]. In allergic
animal models, pre-treatment with capsaicin to degenerate the airway TRPV1-expressing
afferents and to deplete sensory neuropeptides, inhibits allergen-induced airway
constriction in sensitized guinea pigs [29] and AHR in allergic rabbits [61], suggesting an
important role for these airway sensory nerves. In a mouse model of non-atopic asthma,
dinitrofluorobenzene

sensitization

and

challenge

induces

an

accumulation

of

inflammatory cells and AHR; these responses can also be inhibited by capsaicin
pretreatment [62]. Recent studies have further presented convincing evidence of an
important role of TRPV1 in the manifestation of various symptoms of airway
hypersensitivity associated with airway inflammation [63]; for example, bronchomotor
response and cough sensitivity to TRPV1 activators, capsaicin or citric acid aerosol, are
markedly elevated in patients with asthma or airway inflammation [64, 65]. One of the
most prominent pathophysiological features of asthma is bronchial hyperresponsiveness
[66], which is generally believed to be closely associated with endogenous release of
various chemical mediators from inflammatory cells. Recent studies have demonstrated
that some of these inflammatory mediators (e.g., prostaglandins, bradykinin, leukotrienes,
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eosinophil granule-derived cationic proteins, etc.) can markedly enhance the sensitivity of
TRPV1 and lower its threshold for activation (Fig. 1.2) [67]. Furthermore, a recent report
has further revealed a higher tissue temperature in the airways of asthmatic patients [68].
Thus, a given level of stimulation may evoke a greater afferent discharge of the TRPV1expressing C-fiber endings and consequently a more severe bronchoconstriction via both
the central cholinergic pathway and local axon reflex [67] .

Fig. 1.2. TRPV1 is a transducer and an integrator of nociceptive stimuli. (Modified
from Cortight and Szallasi, 2004)
TRPV1 is directly activated by a multiplicity including vanilloids (capsaicin), low pH,
elevated temperature, and arachidonic acid. TRPV1 is indirectly activated through the
protein kinase-mediated signaling pathways by activation of prostaglandin and
bradykinin receptors.
12

1.2 Rationale and Hypothesis
Asthma is characterized by airway inflammation and AHR in response to a
number of bronchoconstrictive stimuli, but the precise mechanism is not clear. AHR
induced by allergen sensitization can be divided into 2 distinct phases, early and late,
based on the timing of the response in relation to antigen exposure. The EAR, which is
due to the contraction of airway smooth muscles induced by the degranulation of mast
cells, occurs within minutes after inhalation of antigen, lasts up to an hour, and is
followed by a rapid return to baseline. The LAR then emerges in 4 to 12 hours after
antigen exposure and may persist for more than 24 hours. There is an accumulation of
inflammatory cells, especially eosinophils, in the airways. These inflammatory cells
cause further tissue damage. Previous studies show that bronchopulmonary capsaicinsensitive afferent fibers (C-fibers) are involved in the development of AHR in asthma
[30, 69]. Endogenous inflammatory mediators released during the allergic reactions can
modulate the excitability of primary C-fiber afferents [70]. Tachykinins such as SP
released from C-fibers are believed to play a part in airway hyperreactivity in guinea pigs.
Enhanced pulmonary C-fiber activity and airway responsiveness to inhaled cigarette
smoke have been observed in ovalbumin (Ova) -sensitized guinea-pigs. In addition, the
excitability of myelinated afferents has been shown to increase during the development of
asthma. Antigen can induce the increased excitability of Aδ myelinated afferents in
isolated guinea pig airways [71]. Challenging the isolated bronchus with a sensitizing
antigen resulted in a transient depolarization of the resting membrane potential of the
guinea pig sensory ganglion [72]. The inflammatory mediators such as NGF can induce
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neuropeptide production in rapidly adapting afferent nerves that do not normally express
these peptides [73]. NGF increased the capsaicin sensitivity of sensory neurons both in
vivo and in vitro [74-77]. Capsaicin is a potent stimulant of pulmonary C-fibers and a
specific agonist of TRPV1 channels. The presence of TRPV1 has been demonstrated in
human airways, mainly in the sensory nerves originating from the vagal ganglia [45-47].
Increased sensitivity of pulmonary C-fibers to capsaicin has been reported in asthmatics
[78]. Activation of TRPV1 in sensory nerves leads to neurotransmitter release from
peripheral

and

central

nerve

endings

resulting

in

neurogenic

inflammatory

bronchoconstriction, mucus hypersecretion and cough [79, 80]. However, the role of
TRPV1 and the relative involvements of different types of bronchopulmonary afferents in
the allergen-induced chronic airway inflammation are not clearly defined.

Hypothesis: Sensitivity of bronchopulmonary afferents is altered during allergeninduced airway inflammation, and an increase in the sensitivity and/or expression of
TRPV1 channels in these sensory neurons is involved. The main objective of these
studies is to test this hypothesis in a well-established animal model of asthma.

Copyright © Guangfan Zhang 2009
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CHAPTER TWO

Study Series 1:
Sensitizing Effects of Chronic Exposure and Acute Inhalation of Ovalbumin Aerosol
on Pulmonary C-fibers in Rats

2.1 Specific Aim
This study was carried out in an animal model of allergen-induced asthma to
investigate: 1) whether the excitability of pulmonary C-fibers in response to mechanical
and chemical stimuli was altered in rats that were sensitized with Ova; and 2) if so,
whether the responses were altered by acute Ova inhalation challenge in sensitized rats.

2.2 Methods
The experimental procedures in study series 1 were performed in accordance with
the recommendations of the Guide for the Care and Use of Laboratory Animals,
published by the National Institutes of Health, and were also approved by the University
of Kentucky Institutional Animal Care and Use Committee.

Animal Sensitization and Allergen Exposure
Pathogen-free male BN rats weighing 250-350 g were divided into two groups
(control and sensitized). Sensitized rats received an initial intraperitoneal (i.p.) injection
of a suspension containing 2 mg Ova in 1 ml Imject Alum as adjuvant. Three days after
the initial intraperitoneal injection, sensitized rats were exposed to Ova aerosol for 15
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min each time, 3 times per week for 3 weeks, following the protocol established by
previous investigators [81]. During exposure, the unanesthetized rat was placed in a
Plexiglas restrainer (University of Kentucky, Center for Manufacturing), and breathed
spontaneously and continuously through a nose cone connected to a free stream of
air/aerosol mixture under a negative-pressure exhaust hood (Fig. 2.1). The Ova solution
(wt/vol concentration: 1.25% in saline) was nebulized and delivered by an ultrasonic
nebulizer (Model 099HD; Devilbiss) at a droplet size ranging from 0.5 to 5 µm. Control
rats received the i.p. injection and aerosol inhalation of the vehicle (isotonic saline)
following the identical procedures.

Animal Preparation
After 3 weeks of either Ova or saline exposure, rats were initially anesthetized with
an i.p. injection of α-chloralose (100 mg/kg) and urethane (500 mg/kg) dissolved in a 2%
borax solution; whenever necessary, supplemental doses (one-tenth of the initial dose) of
the same anesthetics were injected intravenously (i.v.) to maintain abolition of pain
reflexes elicited by paw-pinch. The right femoral artery and the left jugular vein were
cannulated for recording arterial blood pressure (ABP) and administration of
pharmacological agents, respectively; the latter was advanced until its tip was positioned
just above the right atrium. A short tracheal cannula was inserted just below the larynx via
a tracheotomy. Tracheal pressure (Pt) was measured (MP45-28; Validyne) via a side-port
of the tracheal cannula. After a midline thoracotomy was performed, the lung was
artificially ventilated with a respirator (model 7025; UGO Basile), and the expiratory
outlet of the respirator was placed under 3 cmH2O pressure to maintain a near-normal
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functional residual capacity. Volume and frequency were set at ~ 8 ml/kg and 48-50
breaths/min, respectively, to mimic those of unilaterally vagotomized rats. Body
temperature was maintained at ~ 36°C by means of a heating pad placed under the animal
lying in a supine position.

Electrophysiological Recording of Pulmonary C-fiber Activity
Single-unit pulmonary C-fiber activity was recorded as previously described [82].
Briefly, the right cervical vagus nerve was separated from the right carotid artery. The
caudal end of the cut right vagus nerve was placed on a small dissecting platform and
immersed in a pool of mineral oil. A thin filament was teased away from the desheathed
nerve trunk and placed on a platinum–iridium hook electrode. Action potentials were
amplified (P511K; Grass Instruments Co.), monitored by an audio monitor (AM8RS;
Grass Instruments Co.) and displayed on an oscilloscope (model 2211; Tektronix Inc.).
The thin filament was further split until the afferent activity arising from a single unit was
electrically isolated. The nerve trunk was ligated just above the diaphragm to eliminate
afferent signals arising from lower visceral organs. The afferent activity of a single unit
was first searched by hyperinflation (3-4 x VT) and then identified by the immediate
(delay < 1 s) response to a bolus injection of capsaicin (1.0 µg/kg) into the right atrium.
Finally, the general locations of pulmonary C-fibers were identified by their responses to
the gentle pressing of the lungs with a blunt-ended glass rod. The signals of the afferent
activity, Pt and ABP were recorded on a thermal writer (TW11; Gould Instrument
Systems Inc.) and on a VCR format data recorder (SLV-N900; Sony Electronics Inc.).
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Fiber activities (FA) in impulses per second (imp/s) were analyzed by an on-line data
acquisition system (TS-100; Biocybernetics) in 0.5-s intervals.

Inflammatory Cell Analysis in Bronchoalveolar Lavage Fluid (BALF)
BALF was collected from two other groups of rats (control and Ova-sensitized) after
3 weeks of vehicle and Ova exposures, respectively. BALF was obtained by injecting
10 ml of sterile saline (5 ml, twice) into the lungs of the anesthetized rat via a tracheal
cannula. The collected BALF (approximately 7 ml) was centrifuged at 1,500 rpm for
10 min, and the pelleted cells were treated with TRIS-buffered ammonium chloride
solution (pH 7.2) to lyse red blood cells. The remaining cells were washed once with
phosphate-buffered saline, supplemented with 1% fetal calf serum, 100 U/ml penicillin,
100 µg/ml streptomycin, and 250 ng/ml amphotericin (GIBCO). Total cell counts were
determined using a hemocytometer. Differential leukocyte counts were then performed on
cytospin slides after Wright-Giemsa staining. A minimum of 500 leukocytes were
counted using standard morphologic criteria and determined by two different individuals.
The data were then averaged.

Measurements of Lung Mechanics
Control and sensitized rats were anesthetized and artificially ventilated, in the same
manner as that described earlier, one day after the last Ova exposure or vehicle. A
catheter for measuring intrapleural pressure (Ppl) was inserted into the intrapleural cavity
via a surgical incision between the fifth and sixth ribs; this incision was subsequently
sutured and further sealed air-tight with silicone jelly. The pneumothorax was then
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corrected by briefly opening the intrapleural catheter to ambient air during a held
hyperinflation (3 × VT). During the experiment, animals were paralyzed with
pancuronium bromide (50 µg/kg, intravenously). Transpulmonary pressure was measured
as the difference between Pt and Ppl with a differential pressure transducer (Validyne MP
45-28). Respiratory flow was measured with a heated pneumotachograph and a
differential pressure transducer (Validyne MP 45-14). All signals were recorded on a
chart recorder (Grass model 7); total pulmonary resistance (RL) and dynamic lung
compliance (Cdyn) were analyzed continuously by an on-line computer on a breath-bybreath basis (TS-100 series; Biocybernetics).

Acute Ova Inhalation Challenge
Ova aerosol (3%) was delivered directly into the lungs for 5 min; aerosol was
generated by an ultrasonic nebulizer (Lumiscope 6610; Lumiscope Co.) that was
connected between the outlet of the respirator and the tracheal cannula to prevent
contamination of the breathing circuit by the residual Ova. The mass mean diameter of
aerosol under our experimental setting was estimated to be 3-4 µm. To shorten the
protocol in order to maintain the signal stability of single-fiber recording, acute inhalation
Ova challenge was administrated for a shorter duration (5 min) at a higher concentration
of Ova solution (3%).

Methacholine (MCh) Dose-response Curve
To verify AHR, responses of RL and Cdyn to inhalation challenge with increasing
concentrations of MCh aerosol (0.1, 0.3, 1, 3 mg/ml solutions) were determined in each

19

animal. MCh aerosol was generated and delivered in the same manner as described above
for 1 min. There was a 15-min interval between two consecutive MCh aerosol challenges.
The lungs were hyperinflated (3 × VT) at 2 min before each MCh aerosol challenge.

Experimental Protocol
Three series of experiments were carried out. Series 1-1 was carried out to determine
the presence and severity of airway inflammation by differential leukocyte counts of the
BALF on day 21 at 4-6 hours after the last inhalation exposure to Ova aerosol.
Series 1-2 was designed to investigate whether the bronchomotor responses to
inhaled MCh aerosol and acute Ova inhalation challenge were altered by Ova
sensitization in anesthetized rats. On day 24, the dose-response curve to MCh aerosol was
obtained in each of the animals. Subsequently, responses of RL and Cdyn were measured
continuously in each animal before and for 30 min immediately after acute Ova inhalation
challenge.
Series 1-3 was carried out to determine whether the excitability of pulmonary Cfibers was altered by chronic Ova sensitization, and to determine if the changes were
further augmented by acute Ova inhalation challenge. The baseline activities and the
responses to lung inflation and chemical stimulation were determined in anesthetized,
open-chest, and artificially ventilated rats before and within 45 min after acute Ova
challenge in both control and sensitized rats on day 24. The baseline FA was recorded
first followed by the response to lung inflation, and five minutes later the response to
chemical stimulation. A 10-min interval was allowed between two chemical stimulation
trials. Baseline FA was averaged over 60 s in each fiber before and 5-15 min after acute
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Ova challenge (3%, 5 min). Constant-pressure lung inflation was applied by inflating the
lung with a constant air flow (~ 12 ml/s) until Pt reached 15 or 30 cmH2O, and
maintained at that pressure for 10 s after turning off the respirator. Two chemical agents
(capsaicin 0.25 and 0.5 µg/kg; adenosine 75 and 150 µg/kg) were selected as stimulants
of pulmonary C-fibers for the following reasons: capsaicin is a potent stimulant of
pulmonary C-fibers and a selective agonist of TRPV1 [34]; adenosine is a metabolite of
ATP and another pulmonary C-fiber stimulant, but its action is mediated by activating
adenosine A1 receptors [83]. The volume of each bolus injection was 0.15 ml, which was
first slowly injected into the catheter (dead space ~ 0.2 ml) and then flushed into the right
atrium by an injection of 0.4 ml saline before and within 45 min after the acute Ova
challenge (3%, 5 min). Mean arterial blood pressure (MABP) and heart rate (HR) were
measured as 30-s averages before and after acute Ova challenge in both control and
sensitized rats.

Materials
The Ova solution was prepared daily (concentration = 1.25% in saline). Imject Alum
as adjuvant was purchased from Pierce Biotechnology (Rockford, IL). A stock solution of
capsaicin (250 µg/ml) was prepared in 1% Tween 80, 1% ethanol and 98% saline and
stored at - 20°C. Stock solutions of adenosine (10 mg/ml) and methacholine (250 mg/ml)
were prepared in saline and stored at - 20°C. Dilutions of these chemical agents at desired
concentrations for injection or aerosolization were then prepared daily by dilution with
isotonic saline based on the animal's body weight. All chemical agents were purchased
from Sigma Chemical.
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Statistical Analysis
Data were analyzed with a two-way repeated-measure ANOVA, unless mentioned
otherwise. One factor was the treatment effect of Ova, and the other factor was the effect
of lung inflation or chemical agents. When the ANOVA showed a significant interaction,
pair-wise comparisons were made with a post hoc analysis (Fisher's least significant
difference). A P-value < 0.05 was considered significant. Data are reported as
mean ± S.E.M.

2.3 Results
A total of 52 rats (control, n = 26; sensitized, n = 26) were used in this study. The
average body weight of control rats (300.8 ± 3.7 g) was significantly higher than
sensitized rats (279.6 ± 4.4 g; P < 0.05).

Series 1-1: Effect of chronic Ova sensitization on airway inflammatory cells
infiltration
The total number of leukocytes in the BALF collected from sensitized rats (n = 7)
exceeded that of control ones (n = 7) by 73%. In particular, the percentage of eosinophils
(∆ = 1633%; P < 0.01; paired t-test), neutrophils (∆ = 1159%; P < 0.01), and
lymphocytes (∆ = 183%; P < 0.05) in the BALF of sensitized rats were distinctly higher
than that in control rats (Table 2.1).

Series 1-2: Effect of chronic Ova sensitization on bronchial reactivity
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There was no significant difference in the average baseline RL or Cdyn between
control and sensitized rats, but the bronchomotor response to acute Ova aerosol challenge
was significantly higher in sensitized rats (Fig. 2.2). The same Ova inhalation challenge
evoked an intense increase of the RL, which sustained and remained above the baseline
for 30 min after challenge in sensitized rats; in contrast, no detectable change in RL was
found in control rats. The decrease in Cdyn after the Ova inhalation challenge was also
significantly greater in sensitized rats (Fig. 2.2). Even in control rats, Cdyn decreased
significantly below the baseline after acute Ova challenge, which was presumably caused
by the aerosol (liquid) deposition in the lung because the decrease in Cdyn could be readily
reversed by hyperinflation of the lung (data not shown).
Inhalation of MCh aerosol induced an increase in RL and a decrease in Cdyn in a dosedependent manner in both control and sensitized rats (Fig. 2.3). The bronchomotor
responses to MCh aerosol were significantly higher in sensitized rats at the higher
concentrations of MCh (1.0 and 3.0 mg/ml) (Fig. 2.3), verifying the presence of
nonspecific AHR in the sensitized group.

Series 1-3: Effect of Ova sensitization on the excitability of pulmonary C-fibers
A total of 35 pulmonary C-fibers were studied in 28 rats (control rats: 311.9 ± 5.7 g,
n = 14; sensitized rats: 294.4 ± 4.7 g, n = 14). The distribution of these receptors was as
follows: 2 in upper lobe; 7 in middle lobe; 12 in lower lobe, and 6 in accessory lobe; all
were located in the right lung. The locations of remaining 8 pulmonary C-fibers were not
identified, but all of them were activated by lung inflation and a bolus injection of
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capsaicin with a latency of < 1 s; these receptors were therefore considered as pulmonary
C-fibers [33].
Pulmonary C-fibers showed either no or very low and irregular baseline FA in both
control and sensitized rats before acute Ova challenge. However, baseline FA in
sensitized rats (0.36 ± 0.21 imp/s; n = 11) was significantly higher than that in control
rats (0.02 ± 0.01 imp/s; n = 12, P < 0.05) (Fig. 2.4). After the acute Ova challenge, FA in
sensitized rats was further elevated (0.74 ± 0.24 imp/s) and significantly higher than that
in control rats (0.01 ± 0.01 imp/s) (P < 0.01, Fig. 2.4). There was no significant
difference in FA, compared between before and after acute Ova challenge in either
control or sensitized rats, despite that the average baseline FA in sensitized rats was
almost doubled after acute Ova challenge (Fig. 2.4). There was no significant difference
in either baseline MABP or HR between control and sensitized rats (Table 2.2).
The pulmonary C-fiber response to lung inflation was also markedly greater in
sensitized rats. The change in FA (∆FA) in response to lung inflation was calculated as
the difference between the average FA over the 10-s interval during lung inflation and the
baseline FA (60-s average) in each fiber. Before acute Ova challenge, the response to
lung inflation (Pt = 30 cmH2O) in sensitized rats (∆FA = 1.43 ± 0.42 imp/s) was
significantly higher than that in control rats (∆FA = 0.46 ± 0.1 imp/s, P < 0.05); after
acute Ova challenge, the same lung inflation evoked a greater response in both groups,
but the response (∆FA) was greater in sensitized rats (2.83 ± 0.64 imp/s) than in control
rats (0.85 ± 0.19 imp/s, P < 0.05). The FA response to lung inflation was markedly
augmented by acute Ova challenge in sensitized rats (P < 0.01), but not in control rats
(Figs. 2.5 & 2.6). The response to lower intensity of lung inflation (Pt = 15 cmH2O) in
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sensitized rats was significantly higher than that in control rats after acute Ova challenge,
but not before the Ova challenge (Fig. 2.6).
Responses of pulmonary C-fibers to chemical stimulants (capsaicin and adenosine)
were also clearly elevated in sensitized rats. The ∆FA in response to a stimulus was
calculated as the difference between the peak FA and the baseline FA (60-s average) in
each fiber. The peak response of FA was averaged over 2-s and 10-s intervals after
injections of capsaicin and adenosine, respectively, because the fiber discharges evoked
by adenosine lasted substantially longer. Right-atrial injection of capsaicin (0.5 µg/kg)
consistently evoked an abrupt burst of C-fiber activity in both control and sensitized rats,
accompanied by reflex bradycardia and hypotension, presumably mediated through the
C-fiber afferents conducted in the left vagus nerve (e.g., Fig. 2.7). The responses of
pulmonary C-fibers to the high dose (0.5 µg/kg) of capsaicin (∆FA = 12.2 ± 2.3 and 17.5
± 2.6 imp/s, before and after acute Ova challenge, respectively) in sensitized rats were
distinctly higher than those in control rats (∆FA = 4.15 ± 0.86 imp/s and 3.81 ± 0.93
imp/s, before and after acute Ova challenge, respectively; P < 0.05 and P < 0.01) (Figs. 2.
7, 2.8 & 2.9). In sensitized rats, the duration of discharge in response to capsaicin (0.5
µg/kg) was also significantly increased after acute Ova challenge (P < 0.01; Fig. 2.9B).
Interestingly, the decrease in HR and MABP induced by capsaicin appeared to last a
longer duration after acute Ova challenge in both control and sensitized rats (e.g., Fig. 2.7
& 2.8). The pulmonary C-fiber response to the lower dose of capsaicin (0.25 µg/kg) was
also distinctly different between control and sensitized rats, both before and after acute
Ova challenge. These results further showed that the FA responses to capsaicin were
significantly augmented by acute Ova challenge in sensitized rats (P < 0.05) (Fig. 2.9),
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but not in control rats. The differences in response to right-atrial injection of adenosine
between control and sensitized rats were similar but less pronounced, as compared to the
difference in the response to capsaicin between the two groups. The response to the high
dose of adenosine (150 µg/kg) in sensitized rats was higher than that in control rats both
before and after acute Ova challenge, whereas the response to the low dose (75 µg/kg)
was significantly higher in the sensitized rats only after acute Ova inhalation challenge (P
< 0.05) (Fig. 2.10). There was no significant difference in the duration of fiber discharge
after the adenosine injection either between control and sensitized rats, or before and after
acute challenge (Fig. 2.10).
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Table 2.1. Effect of Ova sensitization on leukocyte counts in BALF collected at 4-6
hours after the acute Ova inhalation challenge.
Group
Control,
n=7
Sensitized,
n=7

Total cells Basophils Eosinophils Lymphocytes Monocytes
(×105)
(%)
(%)
(%)
(%)
12.32±2.89 0.00±0.00 0.26±0.07
4.63±1.03
92.97±1.06
21.46±3.95 0.00±0.00 4.46±0.41** 13.14±2.54*

Neutrophils
(%)
2.20±0.71

54.71±8.13* 27.71±8.68**

Data are presented as means ± S.E.M. * (P < 0.05) and * * (P < 0.01), significant
difference between control and sensitized rats (paired t-test).
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Table 2.2. Effects of acute Ova inhalation challenge on average baseline MABP and
HR in both control and sensitized rats.

MABP (mmHg)

HR (beats/min)

Before Ova After Ova Before Ova After Ova
86.1±3.3
Control,
n =14
Sensitized, 91.3±3.1
n =14

96.9±3.4

390.3±5.5

386.9±6.0

102.5±4.5

407.1±6.4

401.3±8.0

MABP and HR were measured before and within 45 min after acute Ova challenge (3%,
5 min). Data are means ± S.E.M.
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Figures
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Ova 5%

Nebulizer

Figure 2.1. Experimental setup for exposure of rats to Ova aerosol.
Panel A: Photographs show a rat placed in the restrainer during aerosol exposure. Note
the small dead space in the nose (marked by arrow) which allows the rat to receive
sufficient Ova/saline aerosol. Panel B: A schematic drawing illustrates the Ova aerosol
delivery system.
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Figure 2.2. Responses of RL (total pulmonary resistance) and Cdyn (dynamic lung
compliance) to acute inhalation of Ova aerosol (3%, 5 min).
Open circles: responses in control animals; filled circles: responses in sensitized animals.
Ova aerosol (3%; 5 min) was delivered into the lung by respirator between the two
arrows. The peak responses were averaged over 20 consecutive breaths at every 2 min
after acute inhalation of Ova in each animal. Data represent means ± S.E.M. of five rats
in each group. * (P < 0.05), significant difference comparing between the baseline and
the response to Ova at different time points in either control or sensitized group; † (P <
0.05), significant difference comparing corresponding data between control and
sensitized groups.

30

Figure 2.3. Dose responses of RL (total pulmonary resistance) and Cdyn (dynamic
lung compliance) to aerosolized methacholine (MCh) in control and sensitized rats.
MCh aerosol was delivered by respirator for 1 min. Peak response to each dose of MCh
aerosol in each animal was averaged over 10 consecutive breaths that occurred within 30
seconds after the MCh aerosol exposure (1 min). Baseline data (zero concentration of
MCh) represent responses to vehicle (isotonic saline). Open circles: responses in control
animals; filled circles: responses in sensitized animals. Data represent means ± S.E.M. of
five rats in each group. * (P < 0.05), significant difference comparing the baseline and the
response to MCh in either control or sensitized group; † (P < 0.05), significant difference
comparing corresponding data between control and sensitized groups.
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Figure 2.4. The average baseline fiber activities before and after acute Ova
challenge in anesthetized, open-chest and artificially ventilated rats.
Baseline FA was averaged over 60 s in each fiber before and 5–15 min after acute Ova
inhalation challenge (3%, 5 min). Open bars: control rats, n = 12; close bars: sensitized
rats, n = 11. * (P < 0.05) and ** (P < 0.01), significantly different between corresponding
data in control and sensitized rats. Data are mean ± S.E.M.
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Figure 2.5. Experimental records illustrating the effects of acute Ova challenge on
the pulmonary C-fiber responses to lung inflation in anesthetized, open-chest and
artificially ventilated rats.
Left and right panels, responses to lung inflation (Pt = 30 cmH2O for 10 s) before and at ~
15 min after acute Ova challenge (3%, 5 min), respectively. AP, action potential; Pt,
tracheal pressure; ABP, arterial blood pressure. Receptor location in the control rat (297
g): right lower lobe. Receptor location in the sensitized rat (298 g): right accessory lobe.
The large spike at the end of lung inflation in each panel was electrical noise generated
by turning on the respirator.
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Figure 2.6. Effect of Ova sensitization on the average responses of pulmonary Cfibers to lung inflation in anesthetized, open-chest and artificially ventilated rats.
Left and right panels, average responses to lung inflation at Pt of 15 and 30 cmH2O,
respectively. Open bars: control rats, n = 13; closed bars: sensitized rats, n = 16 in left
panel, and n = 15 in right panel. Responses were tested both before and 5-25 min after
acute Ova challenge (3%, 5 min) in both control and sensitized rats. ∆FA represents the
difference between the average FA over the 10-s interval during lung inflation and the
average baseline FA (over 60 s) in each fiber. * (P < 0.05) and ** (P < 0.01), significant
difference in responses between control and sensitized rats; † (P < 0.05) and †† (P <
0.01), significant difference in responses between before and after acute Ova challenge in
either control or sensitized rats. Data are means ± S.E.M.
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Figure 2.7. Experimental records illustrating the effects of acute Ova inhalation
challenge on the pulmonary C-fiber responses to capsaicin in anesthetized, openchest and artificially ventilated rats.
Left panel, responses to capsaicin (0.5 µg/kg in 0.15 ml volume) that was slowly injected
into the catheter and then flushed (at arrow) into the right atrium as a bolus with saline
(0.4 ml) before acute Ova challenge (3%, 5 min); right panel, responses to the same dose
of capsaicin at ~ 30 min after acute Ova inhalation challenge. Receptor location in control
rat (300 g): right lower lobe. Receptor location in sensitized rat (285 g): right lower lobe.
For detailed descriptions, see legend of Fig. 2.5.
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Figure 2.8. Effects of acute Ova inhalation challenge on pulmonary C-fiber activity
and cardiovascular responses to capsaicin in anesthetized and open-chest rats.
Left and right panels: the FA and cardiovascular responses to right-atrial injection of
capsaicin (0.5 µg/kg) in both control (open circles, n = 13) and sensitized (closed circles,
n = 15) rats before and 15-30 min after acute Ova challenge (3%, 5 min), respectively.
MABP, mean arterial blood pressure; HR, heart rate. Dashed vertical line depicts the time
of capsaicin injection.
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Figure 2.9.

Effect of Ova sensitization on the average peak response and the

duration of discharge of pulmonary C-fibers in response to right-atrial bolus
injection of capsaicin in anesthetized, open-chest and artificially ventilated rats.
Panel A and B, average peak responses (top) and durations of discharge (bottom) of
pulmonary C-fibers in response to right-atrial injections of capsaicin at 0.25 and 0.5
µg/kg, respectively. Open bars: control rats, n = 11 in panel A, n = 13 in panel B; closed
bars: sensitized rats, n = 10 in panel A, n = 15 in panel B. ∆FA represents the difference
between the peak FA (average over 2-s interval) within 5 s after the injection and the
baseline FA (average over 60-s interval) in each fiber. Duration of discharge was
calculated as the time when FA exceeded the average baseline FA by 1 imp/s. Responses
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were tested before and 15-30 min after the acute Ova challenge (3%, 5 min) in both
control and sensitized rats. * (P < 0.05) and ** (P < 0.01), significant difference in the
response or the duration of discharge between control and sensitized rats; † (P < 0.05)
and †† (P < 0.01), significant difference in the response or the duration of the discharge
between before and after acute Ova challenge. Data are means ± S.E.M.
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Figure 2.10. Effect of Ova sensitization on the average peak response and the
duration of discharge of pulmonary C-fibers in response to right-atrial bolus
injection of adenosine in anesthetized, open-chest and artificially ventilated rats.
Panels A and B, average peak responses (top) and durations of discharge (bottom) of
pulmonary C-fibers in response to right-atrial injections of adenosine at 75 and 150 µg/kg,
respectively. Open bars: control rats, n = 12; closed bars: sensitized rats, n = 12. ∆FA
represents the difference between the peak FA (average over 10-s interval) and the
baseline FA (average over 60-s interval) in each fiber. Duration of discharge was
calculated as the time when FA exceeded the average baseline FA by 0.5 imp/s.
Responses were tested before and 25-45 min after acute Ova challenge (3%, 5 min) in
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both control and sensitized rats. * (P < 0.05), significant difference in the response
between control and sensitized rats. Data are means ± S.E.M.

Copyright © Guangfan Zhang 2009
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CHAPTER THREE

Study Series 2:
Altered Expression of TRPV1 and Sensitivity to Capsaicin in Pulmonary
Myelinated Afferents following Chronic Airway Inflammation in the Rat

3.1 Specific Aim
The present study was carried out to investigate: 1) whether the sensitivity of
vagal myelinated afferents to capsaicin is altered in Ova-sensitized rats; and 2) If so,
whether the expression of the TRPV1 channel is upregulated in pulmonary sensory
neurons of the nodose and jugular ganglia.

3.2 Methods
The experimental procedures in study series 2 were performed in accordance with
the recommendations of the Guide for the Care and Use of Laboratory Animals, and were
also approved by the University of Kentucky Institutional Animal Care and Use
Committee.

Allergen Sensitization and Animal Exposure
Adult male BN rats were separated into 2 groups (control, n = 19; sensitized, n = 21).
Sensitized rats received the same sensitization procedure as described in Chapter 2,
except the concentration of Ova solution was increased to 5% (wt/vol concentration: 5%
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in saline). Control rats received i.p. injection and aerosol inhalation of the vehicle
(isotonic saline) following the identical procedures as sensitized rats.

Animal Preparation
After 3 weeks of either Ova or saline exposure, rats were anesthetized, and trachea,
femoral artery and left jugular vein were cannulated for measuring Pt, ABP and
administration of pharmacological agents, respectively. For detailed descriptions of other
procedures, see Chapter 2.

Measurements of Pulmonary Chemoreflex Responses
Rats breathed spontaneously via the tracheal cannula. Respiratory flow was
measured with a heated pneumotachograph connected to the tracheal cannula and a
differential pressure transducer (Validyne MP45-14), and integrated to give VT. f,
expiratory duration (TE), ABP, and HR were analyzed (TS-100; Biocybernetics) on a
breath-by-breath basis by an on-line computer.

Measurement of Single Fiber Activity
Pulmonary single-unit fiber activities were recorded in anesthetized, vagotomized,
open-chest and artificially ventilated rats, as described in details in Chapter 2 [33]. Briefly,
after a midline thoracotomy was performed, the lung was artificially ventilated with a
respirator (Model 7025; UGO Basile); the expiratory outlet of the respirator was placed
under 3 cmH2O pressure to maintain a near-normal functional residual capacity. Volume
and frequency were set at ~8 ml/kg and 48-50 breaths/min, respectively. To prevent a
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possible indirect stimulatory effect caused by reflex bronchoconstriction on these
afferents, bilateral vagotomy was performed on these animals. The caudal end of the cut
right vagus nerve was placed on a small dissecting platform and immersed in a pool of
mineral oil. A thin filament was teased away from the desheathed nerve trunk and further
split until the afferent activity arising from a single unit was electrically isolated. The
nerve trunk was ligated just above the diaphragm to eliminate afferent signals arising
from lower visceral organs.
SARs and RARs were searched initially by their responses to lung inflation and
deflation, and then further identified by their adaptation indexes (AIs) in response to lung
inflation; AI was calculated in each fiber by dividing the difference in fiber activity (FA)
between the first two seconds during a constant-pressure (Pt = 30 cmH2O) lung inflation
by the FA of the first second, and expressed as a percentage [84]. Fibers with AIs of <
80% and > 80% were classified as SARs and RARs, respectively. The signals of the
afferent activity, Pt and ABP were recorded on a thermal writer (Gould TW11; Gould
Instrument Inc.), and analyzed by a computer and a data acquisition system (TS-100;
Biocybernetics) in 0.1 s intervals.

Measurement of Conduction Velocity
As described in details previously [33], we isolated the intrathoracic segment of
the right vagus nerve in each animal, and placed a pair of stimulating electrodes under the
vagus nerve above the exit of its pulmonary branches. A rectangular constant-current
pulse (duration: 0.1-0.3 ms; intensity: 0.2-1.0 mA) was generated by a pulse generator
(WPI A310) and a stimulus isolation unit (WPI A360R-C), and delivered to the
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stimulatory electrodes. The exact distance between stimulating and recording electrodes
was measured to calculate the conduction velocity. The general locations of all fibers
were identified by their responses to gently pressing the lungs with a saline-wetted cotton
Q-tip. Only receptors with their locations identified in the lung or airways were included
for data analysis in this study. Finally, animals were euthanized after the experiment by
an i.v. injection of KCl.

Retrograde Neuronal Tracing
The cell bodies of sensory neurons innervating the lungs and airways were
identified by retrograde labeling from the lungs using the fluorescent tracer, 1,1’dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine

perchlorate

(DiI;

Sigma).

A

polyethylene catheter (PE-150) was inserted into the trachea of the anesthetized
(pentobarbital sodium, i.p., 40 mg/kg) rat via larynx, and its tip was positioned above the
thoracic inlet. DiI (1 mg/ml) was sonicated and dissolved in ethanol, diluted in saline (1%
ethanol vol/vol), and instilled into the lungs (0.2 ml x 2) with the animal's head tilted up at
~30°. Five days later, the rats were subjected to chronic exposure to saline or Ova aerosol.

Tissue preparation
On day 24 (three days after the last exposure to saline or Ova aerosol), rats were
anesthetized with halothane inhalation, euthanized and transcardially perfused with
0.01M phosphate-buffered saline (PBS), followed by freshly prepared 0.01 M phosphate
buffer (pH 7.4) containing 4% paraformaldehyde. The nodose and jugular ganglia were
dissected and fixed in 4% paraformaldehyde for 4 hours. The ganglia were incubated in
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20% sucrose in PBS overnight at 4°C, embedded in Tissue-Tek OCT compound (VWR
Scientific), and frozen in dry ice for serial cryosectioning at 12 µm on a cryostat
(Model550; MICROM International GmbH). The sections were mounted on SuperFrost
Plus slides (Fisher Scientific), and air dried.

Immunohistochemistry
Tissue sections were first pre-incubated for 1 h at room temperature with 0.01 M
PBS containing 5% normal donkey serum to block non-specific protein binding sites.
Then, the sections were incubated in a mixture of 1:500 TRPV1 antibody (rabbit
polyclonal antibody), or in combination with 1:1000 neurofilament (NF) 160/200
antibody (mouse monoclonal antibody) overnight at 4°C, which were each diluted in PBS
containing 5% normal donkey serum and 0.1% Triton X-100. After three 10-min washes
in PBS, the sections were incubated with a mixture of 1:200 FITC conjugated donkey
anti-rabbit IgG and 1:200 AMCA conjugated donkey anti-mouse IgG for 1 h at room
temperature. Finally, the sections were washed again in PBS and mounted in
Vectorshield (Vector Laboratories).
The immunoreactivity of each neuron was analyzed using epifluorescence
microscopy (Zeiss Axiovert 100AV) with appropriate filter combinations. DiI was
detected with the filter module (wavelengths of 552 nm for excitation and 565 nm for
emission); FITC (495 nm excitation and 528 nm emission); AMCA (353 nm excitation
and 440 nm emission). The sections were visualized with an AxioCam MRc color CCD
camera (Zeiss, Inc.). All images were captured using the same brightness and contrast
setting.
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The specificity of the TRPV1 antibody used in this study was tested in two
separate procedures (Fig. 3.1A & B): 1) applying TRPV1 antibody to the nodose-jugular
ganglia of TRPV1-null mice (B6.129X1-Trpv1tm1Jul/J; the Jackson Laboratory), and 2)
neutralizing the primary antibody with a blocking peptide (Neuromics). Ganglia tested
with either of the two procedures showed no the TRPV1 immunoreactivity. For negative
controls, primary antibodies were omitted (Fig. 3.1C). At least two slides for each animal
were prepared to test as negative controls.

Quantitative Analysis
One nodose and one jugular ganglia were studied in each animal. A total of ~100
sections were obtained from the entire length of each ganglion (~1.5 mm). To avoid
double counting of the same neurons, every eighth section (≥ 96 µm apart) was selected
from serial sections for each ganglion. About 12 sections were analyzed per ganglion in
each trial. Two regions of interest were captured and analyzed per section at 20x
magnification.
Computer-assisted image analysis was used to analyze quantitatively the
expression of TRPV1 and NF immunoreactivity. Digital images were captured using an
Axiovert 100AV microscope with a CCD camera (AxioCam MRc color CCD; Zeiss, Inc.)
interfaced through a Dell Dimensions 4600 computer using Axiovision 4.6 software (Carl
Zeiss Imaging Systems). The TRPV1, NF and DiI thresholds were set based on their
densities on the control slides. DiI-labeled, TRPV1-positive and NF-positive neurons
were counted separately, and co-localizations were determined for each region. The
proportion of a neuron phenotype in a given population of neurons is expressed in
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percentage and then averaged for group analysis; for example, the percentage of TRPV1positive neurons in pulmonary (DiI-labeled) neurons was determined in each section, and
averaged for the entire ganglion in each animal. Data were then pooled in each group of
animals for statistical analysis.

Experimental Design and Protocol
Three series of experiments were carried out: in Series 2-1, we investigated the
effect of Ova sensitization on pulmonary chemoreflex sensitivity in anesthetized,
spontaneously breathing rats. The cardiorespiratory reflex responses to right-atrial
injection of the same dose of capsaicin (0.5-1.0 µg/kg) were compared between control
and sensitized rats. To determine the responses mediated through vagal myelinated
afferents to capsaicin, perineural capsaicin treatment (PNCT) of both cervical vagus
nerves was applied to selectively block the neural conduction in vagal C-fiber afferents as
described previously [85]. Briefly, cotton strips soaked in capsaicin solution (250 µg/ml)
were wrapped around a 2–3 mm segment of the isolated cervical vagus nerves for 30 min.
The apneic response to right-atrial injection of capsaicin was measured as the ratio
between apneic duration and baseline TE; apneic duration is the longest TE occurring
within 5 s after the capsaicin injection.
In Series 2-2, the effects of Ova sensitization on the baseline FA and the
responses of RARs and SARs to lung inflation and capsaicin were determined. Baseline
FA was averaged over 20 consecutive breaths in each fiber. Constant-pressure lung
inflation was applied by inflating the lung with a constant air flow (~ 12 ml/s) until Pt
reached 30 cmH2O, and maintained at that pressure for 10 s after turning off the respirator.
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Responses to lung inflation were calculated as the FA in the first second during lung
inflation. Capsaicin (0.5 and 1.0 µg/kg) was first injected as a bolus (0.15 ml volume)
into the catheter (dead space ~ 0.2 ml) and then flushed into the right atrium by an
injection of 0.3 ml saline. The ∆FA in response to capsaicin was calculated as the
difference between the peak FA (averaged over 2 consecutive breaths) within 5 s after
capsaicin injection and the baseline FA (averaged over 20 consecutive breaths) in each
fiber. To avoid any accumulated effect, at least 10 min elapsed between two injections.
Series 2-3 was carried out to investigate whether the ratios of TRPV1-positive
neurons in pulmonary myelinated and non-myelinated neurons have been altered by Ova
sensitization. NF has been used as the specific marker for identifying myelinated neurons
[86, 87]. Thus, DiI-labeled NF-positive neurons were considered as pulmonary
myelinated neurons. The number of pulmonary non-myelinated neurons (DiI-labeled NFnegative) was calculated as the number of pulmonary neurons (DiI-labeled) minus the
number of pulmonary myelinated neurons (DiI-labeled NF-positive).

Materials
Solution of Ova was prepared daily at the concentration described earlier. Solutions
of chemical agents at the desired concentrations for injection or aerosolization were
prepared daily by dilution with isotonic saline based on the animal's body weight. All
chemical agents were purchased from Sigma Chemical, except Imject Alum (Pierce
Biotechnology); rabbit polyclonal TRPV1 antibody (Chemicon Inc); FITC conjugated
donkey anti-rabbit IgG, AMCA conjugated donkey anti-mouse IgG and normal donkey
serum (Jackson ImmunoResearch Labs).
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Statistical Analysis
Statistical analysis of the difference in the responses between control and
sensitized groups was performed using one-way or two-way ANOVA. When the twoway ANOVA showed a significant interaction, pairwise comparisons were made with a
post hoc analysis (Fisher's least significant difference). A P-value < 0.05 was considered
significant. Data were reported as mean ± S.E.M.

3.3 Results
A total of 40 adult male BN rats were used in this study. Average body weight of
sensitized rats was significantly lower (266.7 ± 5.5 g; n = 21) than that of control rats
(300.4 ± 5.6 g; n = 19, P < 0.01).

Series 2-1:

Effect of chronic Ova sensitization on reflex responses induced by

activation of pulmonary C-fibers and RARs
In anesthetized, spontaneously breathing rats, right-atrial injection of capsaicin
(0.5-1.0 µg/kg) immediately elicited apnea, bradycardia and hypotension in control rats;
these “pulmonary chemoreflex” responses are well documented in the literature and
known to be mediated through stimulation of pulmonary C-fiber afferents [23, 48]. In
comparison, the same dose of capsaicin challenge elicited clearly more pronounced
pulmonary chemoreflex responses in Ova-sensitized rats (e.g., Fig. 3.2). The apneic ratio
(apneic duration /average baseline TE) was 265 ± 88 % in control rats (n = 7), and 605 ±
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193 % in sensitized rats (n = 7; P < 0.05) after injection of low dose of capsaicin (0.5
µg/kg). More importantly, capsaicin injection frequently elicited an augmented breath
(inspiratory VT exceeding the baseline VT by twofold), which usually occurred shortly
following the initial apnea in sensitized rats, but not in control rats (e.g., Fig. 3.2).
Augmented breath is a vagal-mediated reflex response known to be triggered by
activation of RARs [88, 89] and can be completely eliminated by vagotomy (data not
shown). Furthermore, after the C-fiber conduction was selectively blocked by PNCT of
both cervical vagus nerves, the same capsaicin injection no longer elicited the apnea,
whereas the occurrence of augmented breath became more consistent and its volume was
further amplified in sensitized rats (Fig. 3.2), probably resulting from the removal of Cfiber mediated respiratory inhibition by PNCT [88]. Results of this series imply that
sensitivity to capsaicin of RARs was elevated in Ova-sensitized rats.

Series 2-2: Effect of Ova sensitization on the excitability of myelinated afferents
A total of 75 vagal bronchopulmonary afferents were studied in 18 anesthetized,
open-chest rats (18 RARs and 13 SARs in 8 control rats and 26 RARs and 18 SARs in
10 sensitized rats): in control rats, 9.6, 41.9, 38.6 and 12.9% receptors were in upper,
middle, lower and accessory lobes, respectively; in sensitized rats, 17.8, 46.7, 28.9 and
6.6% receptors were in upper, middle, lower and accessory lobes, respectively. The
average conduction velocities were 12.6 ± 1.5 m/s for RARs and 14.8 ± 2.0 m/s for SARs
in the control group, and were 13.2 ± 1.5 m/s for RARs and 15.2 ± 1.7 m/s for SARs in
the sensitized group; no significant difference in the conduction velocity was found
between control and sensitized rats in either RARs or SARs.
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Approximately a half of the RARs exhibited distinct phasic baseline activity that
was synchronous with either expiratory or inspiratory phase of respiratory cycles. The
remaining RARs had no detectable or very little respiratory-related baseline activity (Fig.
3.3). These two types of RARs were named as phasic RARs and silent RARs in this study;
in order to balance the distribution, the same number of each of these two types of RARs
was selected from both control and sensitized groups for this study. In phasic RAR
groups, there was no significant difference in the intensity and pattern of the baseline
activity between control (3.7 ± 1.8 impulses/breath (imp/breath), n = 9) and sensitized
rats (6.2 ± 1.7 imp/breath, n = 13) (Fig. 3.4). Similarly, in silent RAR groups, there was
also no significant difference in the baseline activity between control (0.2 ± 0.1
imp/breath, n = 9) and sensitized rats (0.3 ± 0.1 imp/breath, n = 13). When constantpressure lung inflation (Pt = 30 cmH2O) was applied for 10 s, the discharge in RARs
increased abruptly in response to inflation and then rapidly declined despite the
maintained Pt (Fig. 3.3). When lung deflation was applied by exposing the expiratory
outlet of the respirator to atmospheric pressure (Pt = 0 cmH2O), the activity of RARs
increased and did not show any sign of rapid adaptation during the prolonged deflation
(e.g., Fig. 3.3). In phasic RARs, the FA in response to lung inflation in the first second
were 4.4 ± 1.6 and 15.5 ± 5.7 impulses in control (n = 9) and sensitized rats (n = 13) (Fig.
3.5), respectively, but there was no significant difference between them (P = 0.13). In
view of the three-fold difference in the responses and the small sample size of these data, a
non-parametric statistical analysis (Wilcox rank sum test) was also applied, but a significant
difference was not found (P = 0.18) in the response. Similarly, in silent RARs, there was
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also no significant difference in the first-second response to the lung inflation between
control and sensitized rats (Figs. 3.3 & 3.4).
In sharp contrast, the responses of these afferents to capsaicin were markedly
elevated in sensitized rats. In silent RARs, the high dose (1 µg/kg) of capsaicin triggered
a significantly higher discharge in sensitized rats (∆FA = 3.2 ± 0.9 imp/breath, n = 13)
than those in control rats (∆FA = 0.5 ± 0.3 imp/breath, n = 9, P < 0.05; Figs. 3.3 & 3.6B).
The response of phasic RARs to the same dose of capsaicin showed a similar pattern as
that in silent RARs (Fig. 3.6B; in control rats, ∆FA = 0.9 ± 0.4 imp/breath, n = 9; in
sensitized rats, ∆FA = 12.4 ± 3.3 imp/breath, n = 13; P < 0.01).
All of the SARs (13 in control and 18 in sensitized rats) exhibited distinct phasic
baseline activity that peaked during the inspiratory phase of the respiratory cycles. The
discharge of SARs showed very little adaptation during the constant-pressure lung
inflation (AI < 80%), but ceased during deflation (e.g., Fig. 3.5). No significant
difference in either the baseline activity (FA = 15.8 ± 6.1 imp/breath and 17.8 ± 5.0
imp/breath in control and sensitized rats, respectively) or the responses to lung inflation
in the first second (FA = 68.5 ± 11.5 impulses and 86.1 ± 18.0 impulses, in control and
sensitized rats, respectively) was found between the two groups (Fig. 3.4). In contrast, the
response to capsaicin (1 µg/kg) was significantly elevated in sensitized rats (∆FA = 8.1 ±
2.2 imp/breath, n = 18) compared to controls (∆FA = 2.3 ± 1.3 imp/breath, n = 13, P <
0.05) (Figs. 3.5 & 3.6B).
When all the pulmonary myelinated afferents, including both RARs and SARs
were grouped together, right-atrial injection of either low or high dose of capsaicin
evoked significantly higher responses in sensitized rats than in controls (e.g., at the
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capsaicin dose of 1.0 µg/kg, ∆FA = 7.9 ± 1.4 imp/breath, n = 44 in sensitized rats, ∆FA =
1.4 ± 0.7 imp/breath, n = 31 in control rats; P < 0.01; Fig. 3.6A).

Series 2-3: Effect of Ova sensitization on the expression of TRPV1 channels in both
nodose and jugular ganglia
To investigate whether TRPV1 expression in pulmonary neurons in nodose and
jugular ganglia is altered by Ova sensitization, bronchopulmonary neurons were
identified using DiI labeling. In nodose ganglia obtained from control rats, 35.1% of the
neurons were retrogradely labeled with DiI, which was similar to that of sensitized rats
(33.6%). Among these DiI-labeled neurons, 68.1 ± 1.3% exhibited TRPV1
immunoreactivity in control rats. In comparison, a significantly higher percentage of the
DiI-labeled neurons (80.9 ± 1.2%; n = 4, P < 0.05) expressed TRPV1 in sensitized rats
(Fig. 3.7A). To further investigate the relative increase of TRPV1 expression in
myelinated and non-myelinated neurons, we used NF immunoreactivity as the criterion to
identify myelinated neurons. Previous studies showed that all NF positive neurons were
large, myelinated neurons and essentially all NF-negative neurons were small,
nonmyelinated C neurons [87]. Among these DiI-labeled neurons, 32.8 ± 1.6% and 36.1
± 2.1% were NF-positive neurons in control and sensitized rats, respectively (Fig. 3.8A).
The percentage of TRPV1-positive pulmonary myelinated (DiI-labeled and NF-positive)
neurons was significantly higher in sensitized rats (73.7 ± 1.5%) than in control rats (47.8
± 1.6%; n = 4, P < 0.05) (Figs. 3.8B & C). Surprisingly, there was no significant
difference in the percentage of TRPV1-immunoreactive pulmonary nonmyelinated (C-)
(NF-negative and DiI-labeled) neurons between control (78.1 ± 1.7%) and sensitized rats
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(85.1 ± 1.5%; n = 4, P > 0.05) (Fig. 3.8B). Thus, the staining for TRPV1 in nodose
ganglia revealed a substantial increase of TRPV1 expression in DiI-labeled neurons
induced by sensitization. The increase was mainly found in NF-positive DiI-labeled
neurons (Table 3.1; Figs. 3.8B & C).
Among jugular ganglion neurons obtained from the same groups of animals,
approximately 28.5 ± 0.4% were labeled with DiI in control rats, which was not
significantly different from those of the jugular neurons in sensitized rats (30.5 ± 1.5%).
There was no difference in TRPV1 expression in DiI-labeled neurons between control
and sensitized rats (61.5 ± 3.0% in control rats; 63.8 ± 2.5% in sensitized rats; Fig. 3.7B).
Furthermore, 31.8 ± 1.8% and 28.5 ± 1.8% of the DiI-labeled neurons in control and
sensitized rats, respectively, were NF positive (Fig. 3.9A). In contrast to what we found
in nodose ganglia, the expression of TRPV1 in DiI-labeled NF-positive neurons was not
different between control and sensitized rats. The percentages of TRPV1-positive
neurons in bronchopulmonary myelinated neurons were 51.5 ± 1.1% and 47.9 ± 0.6% (P
> 0.05) in control and sensitized rats, respectively (Fig. 3.9B). Therefore, TRPV1
expression in either myelinated or non-myelinated neurons was not altered by Ova
sensitization in jugular ganglia (Table 3.1).
To avoid possible bias and to verify data accuracy, the quantitative
immunohistochemistry analyses were re-performed in 21% of the images that were
randomly selected from both groups and blindly coded by a person unfamiliar with the
experiment. The difference between the two analyses of the same slides was relatively
small; for example, the differences for NF, DiI and TRPV1 stainings were 2.1 ± 0.4%,
4.1 ± 0.8% and 2.6 ± 0.4%, respectively.
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Table 3.1. Expression of TRPV1-immunoreactivity in myelinated and nonmyelinated pulmonary neurons in nodose and jugular ganglia.

Nodose
(%)
Control
Sensitized

Jugular
(%)
Control
Sensitized

DiI/All

NF(+)/DiI

NF(-)/DiI

TRPV1(+)/DiI

35.1 ± 1.6 32.8 ± 1.6
33.6 ± 2.6 36.1± 2.1

66.2 ± 1.6
63.9± 2.1

68.1 ± 1.3
80.9 ± 1.2*

DiI/All

NF(+)/DiI

NF(-)/DiI

TRPV1(+)/DiI

28.5 ± 0.4
30.5 ± 1.5

31.8 ± 1.8
28.5 ± 1.8

67.2 ± 1.9
70.5 ± 1.9

61.5 ± 3.0
63.8 ± 2.5

TRPV1(+)
/DiI NF(+)
47.8 ± 1.6
73.7 ± 1.5*

TRPV1(+)
/DiI NF(-)
78.1 ± 1.7
85.1 ± 1.5

TRPV1(+)
/DiI NF(+)
51.5 ± 1.1
47.9 ± 0.6

TRPV1(+)
/DiI NF(-)
69.9 ± 4.1
70.0 ± 3.2

The number of DiI-labeled, NF-negative [NF(-)] neurons was calculated by subtracting
the number of DiI-labeled NF-positive neurons from the total number of DiI-labeled
neurons; the TRPV1 expression in pulmonary non-myelinated neurons as the number of
TRPV1-positive DiI-labeled neurons minus the number of TRPV1-postive NF-positive
neurons with DiI. Control rats, n = 4; sensitized rats, n = 4. Values are means ± S.E.M. *,
P < 0.05, significant difference between the corresponding data of control and sensitized
rats.
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Figures

Figure 3.1. TRPV1 antibody specificity test (panels A and B) and IHC controls for
TRPV1 and NF (panel C).
Panel A demonstrates TRPV1 immunoreactivity (TRPV1-IR) in the ganglion of TRPV1
wild type (WT) mice, but not in that of TRPV1-/- mice. Panel B demonstrates that
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preabsorption of the TRPV1 antibody with TRPV1 blocking peptides blocks specific
binding of the antibody to the tissue with only very low non-specific binding. Panel C
shows that omitting the primary antibodies (for TRPV1 and NF) incubation step in the
staining protocol did not result in non-specific binding of the secondary antibodies. Scale
bar: 100 µm.
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Figure 3.2. Experimental records illustrating the effect of perineural capsaicin
treatment (PNCT) of both cervical vagi on cardiorespiratory responses to capsaicin
injection.
Upper, middle and lower panels: responses to right-atrial injection of capsaicin before,
during and after PNCT. Right-atrial injection of capsaicin (1 µg/kg in 0.15-ml volume)
was slowly injected into the catheter and then flushed (at arrow) into the right atrium as a
bolus with saline (0.3 ml). Asterisks were added to depict the augmented breaths. Note
that the augmented breath was consistently elicited by capsaicin in sensitized rat (243 g;
right) and its volume was amplified when C-fiber conduction in the vagus nerve was
selectively blocked either during or after PNCT. Vagal-mediated reflex apnea elicited by
lung inflation (Pt = 10 cmH2O) was not blocked by PNCT in either control or sensitized
rat (records not shown), indicating that neural conduction was intact in myelinated
afferents. Partial recovery of the response was shown at 70 min after the termination of
PNCT in the control rat (257 g; left). Note the augmented breath was always followed
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immediately by a short apnea (e.g., right lower panel), which was probably caused by the
hypocapnia generated by the augmented breath.
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Figure 3.3. Experimental records illustrating the responses of silent RARs to lung
inflation, deflation and capsaicin injection in anesthetized, vagotomized, open-chest
and artificially ventilated rats.
Left, responses to lung inflation (Pt = 30 cmH2O for 10 s); middle, responses to lung
deflation (Pt = 0 cmH2O at the end of expiration); right, responses to right-atrial injection
of capsaicin (1 µg/kg; arrow). Note the lack of bradycardia and hypotensive reflex
responses to capsaicin injection because of the bilateral vagotomy performed in these rats.
AP, action potential; Pt, tracheal pressure; ABP, arterial blood pressure. Control rat (299
g): receptor location, right middle lobe; conduction velocity, 15.3 m/s. Sensitized rat (258
g): receptor location, right lower lobe; conduction velocity, 16.7 m/s.
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Figure 3.4. Average baseline fiber activities (FA) and the responses of silent (si)
RARs, phasic (ph) RARs and SARs to lung inflation in anesthetized, vagotomized,
open-chest and artificially ventilated rats.
Baseline FA was averaged over 20 consecutive breaths in each fiber. Response to lung
inflation was measured as the FA during the first second of lung inflation (Pt = 30
cmH2O). Values are means ± S.E.M. Open bars, control group (n = 9 fibers in A, n = 9 in
B, n = 13 in C); filled bars, sensitized group (n = 13 fibers in A, n = 13 in B, n =18 in C).
No statistical difference was found in any of the corresponding data between control and
sensitized groups.
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Figure 3.5. Experimental records illustrating the responses of SARs to lung inflation,
deflation and capsaicin injection in anesthetized, vagotomized, open-chest and
artificially ventilated rats.
Left, responses to lung inflation (Pt = 30 cmH2O for 10 s); middle, responses to lung
deflation (Pt = 0 cmH2O at the end of expiration); right, responses to right-atrial injection
of capsaicin (1 µg/kg). Control rat (291 g): receptor location, right middle lobe;
conduction velocity, 12.9 m/s. Sensitized rat (272 g): receptor location, right middle lobe;
conduction velocity, 16.3 m/s. For detailed descriptions, see legend of Fig. 3.3.
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Figure 3.6. Effect of Ova sensitization on responses of myelinated afferents to rightatrial injection of capsaicin in anesthetized, vagotomized, open-chest and artificially
ventilated rats.
Panel A: average responses of all the myelinated afferents to right-atrial injection of
capsaicin at 0.5 µg/kg and 1 µg/kg. Open bars, control group (n = 31 fibers); filled bars,
sensitized group (n = 44 fibers). Values are means ± S.E.M. ∆FA, difference between the
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peak FA (averaged over 2 consecutive breaths) within 5 s after capsaicin injection and the
baseline FA (averaged over 20 consecutive breaths) in each fiber. Panel B: Scatterplot
diagrams of the responses of silent RARs, phasic RARs and SARs to right-atrial injection
of capsaicin (1 µg/kg). RAR(si): silent RAR; RAR(ph): phasic RAR. Open circles, data
obtained in control group (n = 9, 9 and 13 in silent RARs, phasic RARs and SARs,
respectively); filled circles, sensitized group (n = 13, 13 and 18 in silent RARs, phasic
RARs and SARs, respectively). Dash line: mean of the ∆FA. *, P < 0.05 and **, P <0.01,
significant difference in the responses between control and sensitized rats. ††, P < 0.01,
significant difference in the responses between low and high doses of capsaicin.
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Figure 3.7. Effect of Ova sensitization on TRPV1 expression in pulmonary neurons
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in nodose and jugular ganglia.
Percentages of DiI-labeled (pulmonary) neurons in all neurons, and TRPV1-positive
neurons in pulmonary neurons in nodose (A) and jugular (B) ganglia. Open bars, average
data obtained from control rats (n = 4); filled bars, sensitized rats (n = 4). Values are
means ± S.E.M. *, P < 0.05, significant difference between control and sensitized rats. C
and D: representative photographs of double-labeling immunohistochemistry of TRPV1
and DiI in nodose (C) and jugular (D) of both control and sensitized rats. Left, TRPV1
staining in green; middle, DiI labeling in red; right, the merged image. Arrows are added
to depict co-localization of TRPV1 staining and DiI labeling in the same neurons.
Asterisks depict the DiI labeled neurons without TRPV1 staining. Scale bar, 100 µm.
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Figure 3.8. Effect of Ova sensitization on TRPV1 expression in NF-positive and NFnegative neurons with DiI labeling in nodose ganglion.
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A: percentages of NF-positive and NF-negative neurons in DiI-labeled pulmonary
neurons. B: percentages of TRPV1-positive neurons in NF-positive and NF-negative
neurons labeled with DiI. Open bars, average data obtained from control rats (n = 4);
filled bars, sensitized rats (n = 4). Values are means ± S.E.M. *, P < 0.05, significant
difference between control and sensitized rats. C: representative photographs of triplelabeling immunohistochemistry of NF, DiI and TRPV1 in nodose ganglia of both control
and sensitized rats. The first column from left, NF staining in blue; second, DiI labeling
in red; third, TRPV1 staining in green; fourth, the merged image. Arrows are added to
depict co-localization of NF staining, DiI labeling and TRPV1 staining in the same
neurons. Asterisks depict the neuron with co-localization of NF staining and DiI labeling,
but without TRPV1 staining. Scale bar, 100 µm.
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Figure 3.9. Effect of Ova sensitization on TRPV1 expression in NF-positive and NFnegative neurons with DiI labeling in jugular ganglion.
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A: percentages of NF-positive and NF-negative neurons in DiI-labeled (pulmonary)
neurons. B: percentages of TRPV1-positive neurons in NF-positive and NF-negative
neurons labeled with DiI. Open bars, average data obtained from control rats (n = 4);
filled bars, sensitized rats (n = 4). Values are means ± S.E.M. C: representative
photographs of triple-labeling immunohistochemistry of NF, DiI and TRPV1 in jugular
ganglia of both control and sensitized rats. For detailed descriptions, see legend of Fig. 3
8. Scale bar, 100 µm.
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CHAPTER FOUR
Discussion and Conclusions

Discussion
The first question raised in this dissertation project was whether the sensitivity of
pulmonary C-fibers is altered by allergen-induced chronic inflammation. The data
revealed in Chapter 2 showed that baseline activity of pulmonary C-fibers was
significantly elevated in rats sensitized by chronic inhalation of aerosolized Ova,
compared to that in control rats. Chronic Ova exposure also produced a distinctly higher
sensitivity of these afferents to chemical stimulants and lung inflation. The increase in
fiber sensitivity to capsaicin was demonstrated by pronounced increases in both the peak
activity and discharge duration in response to the same chemical challenge (Figs. 2.7, 2.8
& 2.9). In addition, after an acute Ova inhalation challenge, the increase in baseline
activity and the excitability were further augmented in sensitized rats. In sharp contrast,
no significant change in the fiber activity or sensitivity was detected in control rats
following the acute Ova inhalation challenge.

Ovalbumin sensitization-induced airway inflammation and AHR
Brown-Norway rats have been established as an excellent animal model of allergic
asthma by previous investigators [12-14]. Many features induced by Ova sensitization are
very similar to those observed in human allergic asthma, including: production of an
antigen-specific immunoglobulin (Ig) E antibody; upregulation of T helper 2 cytokines
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such as interleukin (IL) -4 and IL-5; early and late phase airway responses to the inhaled
antigen; inflammatory cell (e.g., eosinophils, neutrophils) infiltration; and AHR to nonspecific bronchoactive challenge. In the present study, our data showed a significant and
sustained increase of airway resistance to acute Ova challenge in sensitized rats, which
demonstrated the airway hyperreactivity to the antigen challenge (Fig. 2.2). At the same
time, differential cell counts of the BALF revealed inflammatory cell (eosinophils,
neutrophils) infiltration in the airways of sensitized animals (Table 2.1). These results are
therefore in agreement with those reported by previous investigators in the BALF of
sensitized rats [14] and in the sputum of asthmatic patients during asthmatic attack [90].
Furthermore, elevated bronchomotor response to methacholine challenge indicated nonspecific AHR in sensitized rats (Fig. 2.3), which are consistent with those reported by
previous investigators using the same animal model [14, 91].
In Ova-sensitized animals, acute inhalation challenge with aerosolized Ova triggers
early- and late-phase airway responses in the pattern and time course similar to those
found in asthmatic patients after acute exposure to allergens [81, 92, 93]. The early-phase
response, which usually subsides within an hour, is exemplified by severe
bronchoconstriction, mediated primarily by mast-cell derived mediators including
histamine and leukotrienes. Four to six hours later, a more sustained late-phase reaction,
characterized by airway obstruction and inflammatory reaction, develops as a result of
the action of various endogenous inflammatory mediators, cytokines and chemokines
generated by the resident inflammatory cells (e.g., mast cells, macrophages and epithelial
cells) as well as the recruited inflammatory cells (e.g., lymphocytes, neutrophils and
eosinophils) [66].
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Inflammatory mediators released from eosinophils and neutrophils
Extensive evidence suggests a close link of the inflammatory mediators released
from eosinophils and neutrophils to the airway hypersensitivity developed during allergic
airway inflammatory reaction. Eosinophils are one of the primary effector cells in airway
inflammation, and produce a wide range of inflammatory mediators, including granulederived cationic proteins such as eosinophil major basic protein (MBP), lipid mediators
such as prostaglandins and leukotriene C4 (LTC4), and cytokines [94]. Eosinophils may
also localize to airway nerves by recognizing neuronal adhesion molecules [95], which
allows the mediators released from esoinophils to act directly on the airway nerves.
Previous studies demonstrated that activated eosinophils acted directly on DRG neurons
to stimulate the release of neuropeptides and implicated MBP as a key mediator of this
direct effect [96]. Recent studies in our lab showed that intratracheal instillation of
cationic proteins consistently induced intense stimulation and sensitization of pulmonary
C-fibers, and the cationic charge carried by these proteins is primarily responsible for
generating the stimulatory and sensitizing effects on pulmonary C-fiber afferents [63, 97,
98].
Activated eosinophils can also synthesize and secret newly formed lipid mediators,
and some of these mediators are known to exert potent sensitizing effects on pulmonary
C-fibers. For example, PGE2 has been reported to enhance the cough sensitivity to
capsaicin in healthy human volunteers [99]. Indeed, it has been clearly demonstrated that
PGE2 can sensitize pulmonary C-fibers in anesthetized rats [100], as well as isolated
vagal pulmonary sensory neurons [58]. Beside prostaglandins, LTC4, a potent
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bronchoconstrictor, can also stimulate the release of tachykinins from airway afferent
nerve fibers in isolated trachea/bronchus of guinea pigs [101].
Neutrophils are one of the first inflammatory cells to be recruited into the airway
after an allergen challenge [102, 103]. Neutrophils contain an array of products including
lipids, cytokines, proteases, microbicidal products, reactive oxygen species (ROS) and
nitric oxide [104]. Many of these endogenous substances are possible contributors to
airway hypersensitivity. For example, it has been reported that an airway challenge of
aerosolized H2O2, one of ROS known to be released in the airways from eosinophils,
neutrophils and epithelial cells [105], stimulated capsaicin-sensitive vagal pulmonary
afferents in a dose-dependent manner, and that its sensory transduction was mediated
through both TRPV1 and P2X receptors [106]. In addition, several cytokines have also
been suggested to be involved in the sensitization of nociceptors [107]. For example, IL1β, IL-6 and tumor necrosis factor α, can be produced by many cell types, including mast
cells, eosinophils, neutrophils and macrophages in the lung and airways. More recently,
Yu et al. demonstrated that IL-1β stimulated airway nociceptors in anesthetized rabbits
[108].

Inflammatory mediators released from mast cells
After an acute Ova inhalation challenge, the enhanced sensitivity of pulmonary Cfibers was further augmented in sensitized rats. The increased sensitivity occurred
coinciding with the period of early-phase response reported previously in sensitized rats
[93, 109, 110], and mast cell degranulation presumably played a major part of the
reaction; upon exposure to antigen, IgE binds to the high affinity IgE receptor FcεRI
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expressed on the mast cells, and triggers the release of mediators such as histamine,
prostaglandins leukotrienes, and cytokines [111]. Histamine, one of the primary autacoids
secreted from mast cells, is known to have profound effects on a number of airway cells
including sensory nerves [111]. A previous study in our lab showed that inhalation of a
low dose of aerosolized histamine augmented the afferent responses of vagal pulmonary
C-fibers to both lung inflation and right-atrial injection of capsaicin in anesthetized,
open-chest dogs [112].
Tryptase is frequently considered as a marker of mast cell degranulation [113]. An
increased concentration of this protease has been found in BALF of asthmatic patients
[114]. A recent study by Gu and Lee [115] showed that intratracheal instillation of
trypsin significantly amplified the capsaicin-induced pulmonary chemoreflex responses
mediated by pulmonary C-fiber afferents. In isolated vagal pulmonary sensory neurons,
pretreatment with trypsin potentiated the capsaicin-induced whole-cell inward current
[115], and this effect by trypsin is probably mediated though an activation of proteaseactivated receptor-2 (PAR2) and the PKC-dependent transduction pathway. Bradykinin,
released from mast cells and found in the BALF of asthmatic patients [116], has been
shown to stimulate bronchial C-fiber afferents in anesthetized dogs [117]. Similarly, in an
isolated preparation of guinea pig trachea and bronchus, bradykinin activated the C-fiber
sensory terminals innervating these airways, particularly those originating from the
jugular ganglia [118]. Bradykinin is also known to increase the sensitivity of C-fibers in
isolated guinea pig airways and in Ova-sensitized guinea pigs [79, 119]. In addition, 5hydroxytryptamine, another autacoid derived from mast cells, stimulated vagal
bronchopulmonary C-fibers in guinea pig lungs [120]. Together, these studies have
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provided strong evidence suggesting that these mediators derived from mast cell
degranulation are probably responsible for the stimulation and sensitization of pulmonary
C-fibers after acute inhalation challenge with Ova in sensitized rats.

Increased expression and/or sensitivity of TRPV1 in the development of airway
hypersensitivity
Our results illustrating the Ova-induced increase in excitability of these C-fiber
endings to lung inflation have important physiological implications because these endings
are relatively insensitive to changes in lung volume under normal conditions [33].
Furthermore, expansion of the lung is a natural stimulus that occurs commonly in
physiological conditions; for example, an increase in VT can occur upon taking a deep
inspiration (sigh) at rest or during hyperventilation in heavy exercise. Activation of
brochopulmonary C-fibers is known to play a part in evoking the sensation of airway
irritation, cough and reflex bronchoconstriction [23, 48]. Therefore, the hypersensitivity
of pulmonary C-fibers to lung inflation may be involved, at least in part, in generating
these symptoms and airway hypersensitivity found in patients with allergic airway
inflammation.
Capsaicin is a potent stimulant of the pulmonary C-fibers and a selective activator of
the TRPV1 receptor [23, 33, 34, 48]. TRPV1 is a polymodal nociceptive transducer
containing six transmembrane domains that form non-selective, Ca2+-prefering cation
channels. TRPV1 is expressed predominantly in non-myelinated neurons, and can be also
activated by low pH (< 6.0) and high temperature (> 39oC) [34]. Several endogenous
mediators, such as hydrogen ion, anandamide, and certain lipoxygenase metabolites of
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arachidonic acid, can also activate TRPV1 expressed in airway sensory nerves [63, 121].
The involvement of TRPV1 receptors in the development of airway hypersensitivity in
asthma has been suggested. For example, patients with asthma are more sensitive to the
tussive effect of TRPV1 agonists [64]. The sensitivity of capsaicin-induced cough is
increased in asthmatics [64, 65]. In addition, TRPV1 antagonists can inhibit cough
elicited by inhalation of Ova aerosol in sensitized guinea pigs [122]. Previous
investigators have reported increases in the levels of airway acidity, airway temperature
and lipooxygenase metabolites of arachidonic acid in asthmatic patients [59, 68, 123], all
of which are known to activate the TRPV1 [124]. Other inflammatory mediators released
in asthmatic airways (e.g., prostaglandins, bradykinin, etc.) do not activate the TRPV1
directly, but can lower its activation threshold [63, 121]. The present study further
demonstrated a distinctly elevated sensitivity of pulmonary C-fibers to capsaicin in Ovasensitized rats (Figs. 2.8 & 2.9). Since capsaicin is a selective activator of TRPV1, these
results seem to suggest a possible involvement of an increase in the response of TRPV1
channels. I speculate that the enhanced response may have resulted from an increase in
the expression or excitability of TRPV1, or both, in the sensitized rats. Furthermore, my
results suggested that other receptors (e.g. adenosine A1 receptors) were also involved in
the Ova-induced sensitizing effect on pulmonary C-fibers since there were significant
increases in the C-fiber responses to adenosine and lung inflation in sensitized rats [83],
and stimulation of C-fibers by neither of these stimuli is known to involve TRPV1
activation.
Coincidently, results obtained in the Study Series 2-1 carried out in anesthetized
and spontaneously breathing rats further revealed a possibility that chronic airway
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inflammation induced by allergen sensitization might elevate the sensitivity of RARs,
myelinated vagal afferents, to capsaicin (e.g., Fig. 3.2). In order to test this hypothesis,
another series of experiments was carried out to answer the second questions: whether the
sensitivity of vagal myelinated afferents to capsaicin is altered in Ova-sensitized rats and
whether the expression of the TRPV1 channel is upregulated in pulmonary sensory
neurons of the nodose and jugular ganglia.
In Chapter three, experimental data showed that sensitivity to capsaicin of vagal
bronchopulmonary myelinated afferents, including both RARs and SARs, was
significantly elevated when chronic inflammation was induced by allergen sensitization
in

rats.

Consistent

with

electrophysiological

recording

experiments,

our

immunohistochemistry data also showed a significant increase in the proportion of
TRPV1-expressing bronchopulmonary neurons in nodose ganglia of sensitized rats,
compared to that of control rats. This increase of TRPV1 expression was found mainly in
neurofilament-positive neurons (myelinated neurons). Rather surprisingly, we did not
find any significant difference in the proportion of TRPV1-expressing cells in either
myelinated or non-myelinated neurons of the jugular ganglia between control and
sensitized rats.

Over-expression of TRPV1 in pulmonary myelinated afferents
RARs are generally recognized as mechanoreceptors in the lung. These receptors
can be activated by both inflation and deflation of the lung, and a decrease in lung
compliance and an increase in the interstitial fluid volume in the lung [67, 84, 125]. A
small percentage of RARs are also sensitive to various inhaled irritants including

78

cigarette smoke, sulfur dioxide and acid [33, 84]. Stimulation of RARs can elicit reflex
responses such as augmented breath, bronchoconstriction and hypersecretion of mucus.
In addition, a subgroup of RARs are believed to act as cough receptors in response to
inhaled irritants [126]. On the other hand, SARs can be activated by volume expansion of
the lung or an increase in transluminal pressure in the airways [127]. SARs are generally
considered to be insensitive to capsaicin or any other chemical irritants [33]. The activity
arising from SARs is known to play an important role in the regulation of breathing
patterns [17, 18]. Both RARs and SARs are myelinated afferents, as verified by the
measurement of conduction velocity (> 5 m/s) in each fiber. RARs and SARs were
classified based upon their adaptation indexes in response to maintained lung inflation at
30 cmH2O pressure in this study. Similar to that reported in our previous studies [33], the
heterogeneity of the discharge pattern of both SARs and RARs, and the variability of
adaptation index in their responses to different inflation pressures are both quite evident.
A small percentage (~ 20%) of these receptors may fall into the category of “intermediate
type” [128]. However, this variation in the classification criteria between RARs and
SARs should not be viewed as a confounding factor in our conclusion because the overall
response to capsaicin is still markedly greater in the sensitized rats even when the data
from all myelinated afferents (including both RARs and SARs) were pooled for
comparison (Fig. 3.6A)
Capsaicin has been used extensively as a tool for identifying non-myelinated (C-)
nociceptive afferents in various organ systems [129]. A recent study in our lab showed
that right-atrial injection of capsaicin stimulated only 6.3% of the RARs and no SARs in
the lungs of Sprague-Dawley rats [33]. Similar results were also found in the control rats
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in the present study. However, in stark contrast, right-atrial injection of capsaicin exerted
a distinct stimulatory effect on RARs and SARs in Ova-sensitized rats. Thus, these
results demonstrated that chronic airway inflammation induced by Ova sensitization
triggered a phenotypic switch in myelinated bronchopulmonary afferents and clearly
upregulated their sensitivity to capsaicin. The results obtained in immunohistochemistry
experiments further indicate that a high percentage of pulmonary myelinated neurons
expressed TRPV1 when chronic airway inflammation was induced by allergen
sensitization. Therefore, it seems reasonable to hypothesize that the overexpression of
TRPV1 in vagal pulmonary afferents may contribute, at least in part, to the development
of airway hypersensitivity in allergic airways.

Possibly involvement of neurotrophins
The mechanisms possibly responsible for the phenotypic change in TRPV1
expression in pulmonary myelinated neurons are not known. However, neurotrophins
such as brain-derived neurotrophic factor (BDNF) and NGF should be considered
because their synthesis and release have been shown to increase in allergic airways [130,
131]. Furthermore, they are known to upregulate the expression and function of TRPV1
in sensory neurons [74-76]. For example, it has been suggested that BNDF may
contribute to the development of hypersensitive airways since mice treated with antiBNDF antibodies showed reduced neuronal hypersensitivity to capsaicin [132]. Indeed,
BDNF can upregulate the capsaicin sensitivity of nodose ganglion cells in culture [76].
More importantly, the BDNF serum levels are elevated in asthmatic patients [130]. NGF
is another important neurotrophic factor to be considered in the pathogenesis of asthma. It
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has been reported that serum levels of NGF in patients with asthma were positively
correlated with the severity of the disease [131]. Meanwhile, recent studies have clearly
demonstrated that NGF can increase capsaicin sensitivity of sensory neurons both in vivo
and in vitro [74-77], which may be mediated through several possible mechanisms, such
as increasing the expression of the TRPV1 channel protein [133], promoting translocation
of the TRPV1 to cell membrane [54], and modulating the TRPV1 function by releasing
the receptor inhibition from PIP2 [54].
The relationship between those neurotrophins and the expression of TRPV1 may
also help to explain another interesting observation in the present study. Increased
expression of TRPV1 occurred only in nodose pulmonary myelinated neurons, but not in
their jugular counterparts. Different embryonic origins of these two types of ganglia may
play a part in causing this difference. Nodose ganglia have a placodal origin, where as
jugular ganglia arise from the neural crest [32]. It has been suggested that the different
phenotypes of neurons arising from these two ganglia may be related to different
requirements in neurotrophic factors. In the chick embryo, placode-derived neurons, such
as ventrolateral trigeminal neurons [134] and nodose ganglion neurons [135], mainly
survived and grew in the presence of BDNF, whereas neural crest-derived neurons, such
as dorsomedial trigeminal neurons and jugular neurons, were supported preferentially by
NGF [135]. Meanwhile, BDNF is more abundant in the nodose ganglion than in the
jugular ganglion [136, 137]. The majority of nodose ganglion neurons expressed tyrosine
receptor kinase B (TrkB), the preferred receptors for BDNF [45, 138, 139]. Considering
the observation that the level of BDNF, but not NGF, is likely involved in determining
the level of capsaicin sensitivity of vagal sensory neurons [76], we suggest that BDNF
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may be responsible for the inflammation-induced TRPV1 upregulation in nodose ganglia.
This postulation is further supported by the fact that the majority of small neurons of the
nodose ganglion express TRPV1 mRNA in conjunction with BDNF receptor TrkB, but
not NGF receptor TrkA [45]. It has been shown that after nerve injury, small neurons
(usually C neurons) in DRG switched off their normal syntheses of BDNF, whereas large
ones (myelinated neurons) switched to a BDNF phenotype [140], which seems also in
general agreement with our postulation. Taken together, the observations described above
offer compelling support to our hypothesis that these neurotrophic factors may be
involved, at least in part, in the over-expression of TRPV1 in myelinated neurons induced
by allergic airway inflammation. A possible mechanism is that these neurotrophic factors
induce the activation of MAP kinases pathway (p38, ERK, JNK), which cause
transcriptional regulation via transcription factors (CREB, ELK-1, Jun), and/or
translational regulation via translation initiation factors, and finally induce the synthesis
of TRPV1 channels [141]. Obviously, further investigation is required to test this
hypothesis. Furthermore, possible contributions to the TRPV1 upregulation by other
chemical mediators synthesized and released in the airways during the chronic allergic
inflammation can not be overlooked.
An

allergic

inflammation-induced

phenotypic

change

of

neuropeptide

(tachykinins and CGRP) synthesis in sensory nerves has been previously reported in
guinea pig airways [73]. However, the expression of TRPV1 and neuronal sensitivity to
capsaicin were not found in the nodose Aδ neurons innervating the trachea and major
bronchi of Ova-sensitized guinea pigs in that study [73], which is different from our
observation in this study (Figs. 3.7 & 3.8). Possible causes of this discrepancy are not
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known, but may be related to several factors such as the severity of the allergic
inflammation, innervations of different regions of the lung structures, species differences,
or other unknown factors.

Limitations of immunohistochemistry experiments
The expression of TRPV1 immunoreactivity was only determined in neuronal cell
bodies in this study. Therefore, it did not offer any direct evidence of the TRPV1 overexpression in the sensory terminals of myelinated afferents in sensitized rats.
Coincidentally, a recent short study reported the number of TRPV1-positive axons in the
trachea increases in Ova-sensitized guinea pigs [142], which is in general agreement with
our finding. Furthermore, our data in the in-vivo study indicating that the sensitivities of
both RARs and SARs to capsaicin were markedly increased in sensitized rats (Figs. 3.3,
3.5 & 3.6) lend strong support to our conclusion.
In the present study, we did not find a difference between control and sensitized
rats in the percentage of pulmonary non-myelinated (NF-negative) neurons that express
TRPV1 channels. However, we want to emphasize that the contribution of pulmonary Cfiber afferents in the airway hypersensitivity in this allergic asthma model should not be
underestimated. Indeed, we have demonstrated that there was an increase in the
excitability of pulmonary C-fiber to mechanical and chemical stimuli, especially the
increased sensitivity to capsaicin, in Ova-sensitized rats [143]. Furthermore, we also need
to point out a limitation in the data analysis of our immunohistochemistry experiments;
the computer analysis measured only the percentage of bronchopulonary neurons that
expressed the TRPV1 receptor, rather than the density or the total number of the TRPV1
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channels expressed in each neuron. Thus, it is very possible that the density and/or the
sensitivity of TRPV1 channels were elevated in pulmonary non-myelinated neurons of
sensitized rats, despite a lack of increase in the percentage of TRPV1-expressing neurons.
In fact, our recent finding in the in-vivo study [143] has offered intriguing evidence for
such a possibility. Similarly, we can not rule out the possibility that the sensitivity and/or
density of TRPV1 were also upregulated in the jugular pulmonary neurons in sensitized
rats.

Altered sensitivities of TRPV1 and other channels and receptors
Besides the possibility of an increased expression of TRPV1 channels in
pulmonary afferents, it is also possible that the function and properties of TRPV1
channels are modified by certain signaling pathways during airway inflammation [50,
144]. For example, ATP and bradykinin bind to their receptors, which activate PLC. PLC
can cleave PIP2 to yield inositol-1, 4, 5-trisphosphate (IP3) and diacylglycerol (DAG).
DAG is upstream signal to PKC which will directly phosphorylate the serine residues 502
and 800 in TRPV1 protein. At the same time, the hydrolysis of PIP2, a negative regulator
of TRPV1, will release the inhibition of TRPV1. Thus, activation of intracellular PKC
activity results in increased TRPV1 sensitivity to capsaicin. The cAMP dependent PKA
can also directly phosphorylate TRPV1 and increase the excitability of these channels.
Therefore, the increased phospharylated TRPV1 channels in these afferent nerve
terminals could be one of the explanations for the increased sensitivity of sensory nerves
to capsaicin during airway inflammation. Another possibility is that neuromodulators can
change membrane properties of pulmonary afferents by membrane depolarization and an
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increase in membrane resistance, which may cause a lower stimulus threshold and an
increased frequency in action potential [145]. Therefore, the excitability of pulmonary
afferents to capsaicin is increased. For example, PGE2 and histamine inhibit resting
potassium “leak” currents, causing an increase in membrane resistance and a gradual
buildup of cations within the cells, thus producing the minor depolarization. The increase
in membrane resistance will probably result in an increase in the rate and amplitude of
action potentials generated by a given a mount of activating stimulus (e.g., mechanical
perturbation or capsaicin) [145].
In this thesis, my main focus is on the role of TRPV1 channels in the AHR during
allergen-induced airway inflammation. However, there are several other channels which
should not be overlooked in the development of ARH. For example, TRPA1, like TRPV1,
is expressed in vagal sensory nerves innervating the airways [146, 147] and can be
regulated by neurotrophic factors, proteases, and certain autacoids such as bradykinin
[148-150]. TRPA1-selective stimuli can also evoke action potential discharge from
bronchopulmonary C-fibers and consequent defensive reflexes [147]. TRPV4, found on
airway

smooth

muscle

cells,

might

function

in

the

transduction

of

osmolarity/hypotonicity stimuli in airways since hypotonic stimulation induces airway
constriction in normal and asthmatic airways [121, 151]. Part of the bronchoconstriction
is probably mediated through cholinergic reflex since hypotonicity stimulates both Cfiber and rapidly adapting receptors in the airways [121]. Various types of potassium
channel expressed in airway smooth muscle are also involved in modulation of
neurotransmitter release from airway nerves [152]. Acid sensing ion channel (ASIC) and
purinergic receptor subtype X channels (P2Xs) have been suggested to function as
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transducer for nociceptors [153]. Therefore, it is very important for future studies to
identify and characterize the properties of these receptors in the development of AHR in
asthma.

Conclusions
The results obtained from these studies are, in most parts, in support of our
hypothesis. We found that allergen-induced airway inflammation induced a pronounced
sensitizing effect on vagal pulmonary non-myelinated (C-fiber) afferents and altered
sensitivity of vagal pulmonary myelinated afferents to capsaicin which is correlated with
upregualtion of TRPV1 expression in these myelinated neurons.
These findings should help to improve our understanding of the mechanisms
underlying the AHR during allergen-induced asthma. These pulmonary afferents have an
important role in regulating the overall cardiorespiratory function. Both their local axon
reflexes and centrally mediated reflexes elicited by activation of these afferents are
expected to be amplified in allergen-sensitized airways, and cause the deleterious effects
in the respiratory tract during asthma, such as cough, bronchoconstriction, airway
hypersecretion, bronchial vasodilation and neurogenic inflammation [49]. Therefore, our
present study suggested that hypersensitivity of pulmonary afferents plays an important
role in the development and manifestation of AHR induced by allergen sensitization.
Furthermore, the finding of upregulation of TRPV1 sensitivity and expression in these
neurons implies that the antagonist of TRPV1 channels may be a potentially effective
therapeutic treatment for alleviating the allergen-induced AHR.
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However, there are still many questions that remain unanswered in the present
study. For example, further studies will be required to evaluate the relative contributions
of specific types of inflammatory cells and endogenous mediators in the development of
pulmonary C-fiber hypersensitivity, and to identify the signaling pathways possibly
involved in the interaction between inflammatory cells and pulmonary C-fiber endings in
allergen-sensitized airways. In addition, the role of neurotrophic factors in the enhanced
sensitivity of pulmonary myelinated afferents to capsaicin and upregulation of TRPV1
channels expression in these nerves remains to be determined. Lastly, we can not
overlook the possible involvement of an interaction between TRPV1 and other ion
channels (e.g. TTX-resistant Na+) and/or receptors (e.g., P2X3, etc.) in allergen-induced
AHR. It is obvious that mechanisms underlying airway afferent sensitization still need to
be further investigated in the allergen-induced asthma.

Copyright © Guangfan Zhang 2009
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APPENDICES
(LIST OF ABREVIATIONS)
ABP

arterial blood pressure

AHR

airway hyperresponsivenss

AIs

adaptation index

AP

action potential

APCs

antigen presenting cells

ASIC

acid sensing ion channel

BALF

bronchoalveolar lavage fluid

BDNF

brain-derived neurotrophic factor

BN rat

Brown-Norway rat

cAMP

cyclic AMP

Cdyn

dynamic lung compliance

CGRP

calcitonin gene-related peptide

DRG

dorsal root ganglion

EAR

early-phase asthmatic response

f

frequency

FA

fiber activities

∆FA

the change in fiber activities

12-HPHETE

hydroperoxyeicosatetraenoic acids

HR

heart rate

Ig

immunoglobumin

imp/s

impulses per second
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i.p.

intraperitoneal

IP3

inositol-1, 4, 5- trisphosphate

i.v.

intravenous

LAR

late-phase asthmatic response

LTs

leukotrienes

LTB4

leukotriene B4

TH cells

T helper cells

MABP

mean arterial blood pressure

MAP

major basic protein

MAP kinase

mitogen-activated protein kinase

MCh

methacholine

NF

neurofilament

NGF

nerve growth factor

Ova

ovalbumin

PAR2

protease-activated receptor-2

PBS

phosphate-buffered saline

PGs

prostaglandin

PIP2

phosphinositide-4, 5- bisphosphate

PK

protein kinase

PNCT

perineural capsaicin treatment

Ppl

intrapleural pressure

Pt

tracheal pressure

RARs

rapidly adapting receptors
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RL

total pulmonary resistance

ROS

reactive oxygen species

SARs

slowly adapting receptors

SP

substance P

TE

expiratory duration

TRPV

transient receptor potential vanilloid type receptor

TrkB

tyrosine receptor kinase B

VT

tidal volume
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